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ABSTRACT
Cecropins are basic, amphipathic peptides with antibacterial activity against 
many Gram-positive and Gram-negative bacteria. By retaining the positively charged, 
amphipathic characteristic of cecropin B, a cecropin analog 81, in which 54% of amino 
acid residues were substituted, was synthesized and shown to possess a broad spectrum 
of antimicrobial activity.
To determine expression of the cecropin analog 81 in 8f9 cells, two gene 
constructs were designed, and inserted into Auto^apha califomica nuclear 
polyhedrosis virus under the control of the polyhedrin promoter. One construct, pB81, 
consisted of a gene encoding the analog peptide, so that the gene was intended for 
expression in the cytoplasm. The other construct, pBCE81, was designed to be 
expressed as a secretory peptide, consisting of a hybrid gene between a 
preprosequence-encoding region of cecropin B and the analog peptide-encoding gene. 
Expression was observed in the pBCE81 construct but not in the pB81, indicating that 
this peptide is not stable in the cytoplasm. While the expressed peptide was observed 
to be maintained stably, the antibacterial activity of analog peptides was inhibited by 
fetal bovine serum without observation of peptide degradation. This indicates that fetal 
bovine serum binds to the expressed peptides and may help its stable expression.
A gene encoding preprocecropin B was observed to be expressed as 
procecropin B in 8 0  cells, indicating that the cells do not have an enzyme, dipeptidyl 
aminopeptidase, to process the prosequence. While 8 0  cell lysates degraded cecropin
ix
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B, the expressed procecropin B was not degraded in the medium after lysis of Sf9 ceils. 
Unlike the analog peptide, the antibacterial activity of cecropin B was not inhibited by 
fetal bovine serum.
Both peptides were not stably expressed in bacterial expression systems, where 
mature peptide-encoding genes were used for making fusion proteins with protein A or 
maltose-binding protein (MBP). In the protein A fusion system, both peptides were 
observed to be expressed in Staphylococcus aureus but not in Escherichia coli. The 
analog peptide showed more degradation than cecropin B in the MBP fusion system. 
However, none of peptides could be purified in functional form due to precipitate 
formation after a chemical or enzymatic cleavage.
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CHAPTER ONE 
INTRODUCnON
Microorganisms are causative agents of infectious diseases which affect all 
living organisms including humans, animals, and plants. Since the discovery of 
penicillin in 1928 by Alexander Fleming, much effort has been made to develop more 
effective antibiotics to control infectious diseases. Using technological advances, 
antibiotics, that were at one time isolated mainly from microorganisms, can now be 
synthesized chemically. As more antimicrobial agents have been found or synthesized, 
it seemed likely that a variety of disease-causing microorganisms could soon be 
inhibited. However, frequent use of antibiotics has created problems. Pathogens can 
be resistant by acquiring a drug-resistant plasmid or by mutation. In the presence of 
the drug, the drug-resistant pathogen has a selective advantage and may replace the 
drug-sensitive parent strain. Resistance can be developed to virtually all antimicrobial 
agents. This prompts humans to continually seek new antimicrobial agents and attempt 
new ways to control pathogens.
Recent discoveries of various antimicrobial peptides have brought new 
perspectives to the battle against pathogens. The first of these peptides was isolated 
from the hemolymph of Hyalophora cecropia in 1980 by Boman and colleagues 
(Hultmark et al., 1980). Subsequently, different antimicrobial peptides were found in a 
number of animal species including insects, frogs, cows, and humans (Boman, 1995). 
It has become evident that these peptides are widely distributed in nature. Despite their
1
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amino acid sequence diversity, all antimicrobial peptides have a common structural 
moti^ that may explain the mechanism used to kill pathogens. T h ^  are highly basic 
and have a tendency to form amphipathic secondary structures like membrane channel 
proteins. Indeed, it was proposed that antimicrobial peptides kill pathogens by forming 
pores in their cell membranes, rather than targeting specific proteins. As a result, it 
may be difficult for pathogens to have resistance to the peptides, since a modification of 
membrane structure seems to be necessary for allowing pathogenic resistance. In 
addition, the common structural properties make it possible to design new artificial 
antimicrobial peptides by increasing or modifying their biological activities through 
changes in their amino acid sequences. Several synthetic peptides have been designed 
and one cecropin analog, Shiva-1, shows a better antimicrobial activity than its 
naturally occurring counterpart, cecropin B (Jaynes et al., 1988).
Genetic engineering makes it possible to manipulate genetic materials and 
transfer genes into almost any kind of organism or cell. This technique allows for 
production o f large quantities of proteins to be tested as potential therapeutic agents 
for a number of life-threatening diseases. Genes can also be directly introduced into 
animals or plants to provide them with desirable phenotypes such as increased growth 
rate, or disease resistance. Also, therapeutic genes can be introduced into certain types 
of cells temporarily, so that expressed gene products may be used for curing genetic 
disorders or removing infectious pathogens.
The utilization of genes encoding antimicrobial peptides might provide an 
effective way to fight pathogens through gene therapy or transgenic systems. Since the
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common structural motif in their sequences allows for design o f new modified peptides, 
the combination of genetic engineering and peptide design will give new insights for the 
control o f infectious disease in the future.
Statement of the research problem 
The design and synthesis of peptides has been performed in different 
laboratories in the past. However, there is little information available on the utilization 
of synthetic genes for designed lytic peptides. An early attempt was made to introduce 
a cecropin analog peptide-encoding gene into tobacco plants to provide them with 
resistance against plant pathogens (Nagapala, 1990). The gene was designed to be 
expressed as a cytoplasmic peptide. While the gene was transcribed under a wound- 
inducible plant promoter, the expression of peptide was not detected at the peptide- 
level. Since the gene encoded an artificially designed peptide, it was speculated that 
designed peptides might be recognized by host cells as abnormal, and degraded. 
However, subsequent work revealed no peptide expression in transgenic plants carrying 
genes encoding naturally occurring cecropin B (Allefs et al., 1995; Florack et al., 
1995). At this point, it is suggested that transgenic plants or transgenic animals may 
not be good candidates for applying the peptide genes for practical use. Instead, more 
basic studies need to be done to see the usefulness of designed genes to produce 
antimicrobial peptides.
Objective of the research project
The goal of this research is to demonstrate that a biologically active, designed 
antimicrobial peptide can be expressed in a DNA expression system. Cecropin analog
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SI (formerly Shiva-1) was chosen for this purpose since the analog was modified by 
54% amino acid residues fi'om cecropin B and it retained antimicrobial activity. The 
selection of expression system is believed to be important for demonstrating synthetic 
peptide gene expression. A baculovirus expression system was used in this experiment. 
Following are specific objectives of this research.
1) To demonstrate how a designed antimicrobial peptide gene is expressed in the 
baculovirus system.
2) To demonstrate how its native counterpart peptide, cecropin B is expressed in the
baculovirus system.
3) To determine if these peptides, cecropin analog SI and cecropin B, can be 
produced in bacterial expression systems.
Antimicrobial peptides in insects 
Like other organisms, insects have effective immune systems, both cellular and 
humoral. Their host-defense systems consist of mainly innate reactions. Upon injury of 
insects, they immediately activate the two proteolytic cascades leading to localized 
blood clotting and melanization, the phagocytosis by blood cells, and the induced 
synthesis of potent antimicrobial peptides/polypeptides. The cellular immunity seems 
to play a role in insect immunity, but so far, it has been only morphologically analyzed. 
In contrast, the humoral immunity has been extensively studied over the past decade. 
The insect fat body (a fimctional homologue of the mammalian liver) and some blood 
cells play a key role in producing humoral factors that are released into the hemolymph 
and act synergistically to destroy invading microorganisms. Although the immediate
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induction of two proteolytic cascades, which exhibit similarities to the vertebrate acute- 
phase response (HofiSnann et cd., 1993; Hultmark et cd., 1993) are believed to be 
important in killing foreign invaders, the recent discovery of antimicrobial peptides 
emphasized the active involvement of these peptides in host defense.
The injection of insects with live, non-pathogenic bacteria stimulated a 
resistance to a subsequent injection of virulent bacteria. This resistance appeared in the 
cell-free hemolymph and was induced by bacterial challenge. This induction of 
antibacterial activity appeared within a few hours following challenge and the 
antibacterial activity was wide ranging, directed against Gram-positive and Gram- 
negative bacteria. The exact nature o f these antibacterial substances had not been 
biochemically defined until Boman and his associates in the early 1980s isolated and 
characterized the first inducible antibacterial peptides: cecropins and attacins (Hultmark 
et al., 1980). Since then, a significant number of inducible antibacterial peptides have 
been isolated and characterized from various insect species. Some peptides show 
sequence similarities, which indicates a possible evolutionary relationship among them. 
Cecropins
Cecropins were the first inducible antibacterial peptides discovered in the 
hemolymph of diapausing pupae of Hyalophora cecropia after challenge with bacteria. 
In Hyalophora, three cecropins, cecropin A, cecropin B, and cecropin D have been 
identified. They consist of 35 to 37 amino acid residues. Cecropin A (37 residues) and 
cecropin B (35 residues) are highly effective against Gram-positive and Gram-negative 
bacteria while cecropin D (36 residues) shows activity only against Escherichia coli
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and Acinetobacter calcoaceticus (Boman and Hultmark, 1987). Cecropins were later 
discovered in many insect species including the flesh fly Sarcophaga (Okada and 
Natori, 1985), the silkworm. Bombyx (Morishima et a/., 1990), the tobacco homworm 
Manduca (Dickinson et al., 1988) and the fruit fly Drosophila (Kylstein et al., 1990). 
To date, 18 cecropins from insects and one from pig (Lee et al., 1989) have been 
isolated and their amino acid sequences determined.
Each cecropin can be structually separated into two regions; an N-terminal and 
a C-terminal half. The N-terminal half is positively charged and forms an amphipathic 
helical structure in hydrophobic solvents. On the other hand, the C-terminal half shows 
a hydrophobic helical structure. Two halves are connected by a hinge region with 
proline and/or glycine. Consensus residues appear at many positions, among them, Trp 
at position 2 is thought to be important in full biological activity (Andreu et al., 1983; 
Andreu et al., 1985). Also, the carboxyl group of the last amino acid is amidated in all 
cecropins except for that of the porcine.
Genomic DNA and cDNA sequences are available for cecropins from Cecropia 
(van Hofsten et a i, 1985; Gudmundsson et a i, 1991), Manduca (Dickinson et ai,
1988), Sarcophaga (Matusomoto et ai, 1986), and Drosophila (Kylstein et a i, 1990). 
Their DNA sequences reveal that cecropins are synthesized as larger precursors, 
preprocecropins, ranging from 62 to 64 amino acids. The N-terminal 24-26 amino 
acids o f precursors are not present in mature peptides. The signal peptides make up the 
first 22 of these 24-26 amino acids, which leaves the rest of amino acids as 
prosequences. Usually, acidic amino acids (Glu, Asp) and/or small amino acids (Ala,
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Pro) make of the prosequences compared to the basic nature of mature peptides. In 
cecropiOy the prosequence (-Ala-Pro-Glu-Pro-) of cecropins A and B is processed by a 
dipeptidyl aminopeptidase (Boman et al., 1989a). Since all cecropin cDNAs encode a 
glycine residue at their C-terminal end, it is believed that the glycine residue is used for 
the amidation of the C-terminal end. The amidation of C-terminal amino acid of 
cecropins is known to increase antibacterial activity, but the increase is not remarkably 
high. Synthesis and post-translational modification seems to occur mainly in the fat 
body. In D. melanogaster, the cecropin genes are strongly expressed in the fat body 
along with hemocytes after bacterial infection (Samakovlis et al., 1990). Because of 
their small number, the hemocytes seem to contribute little to bulk cecropin production 
but activated hemocytes may produce a locally high concentration of cecropins at the 
site of infection.
Cecropin genes like other inducible genes are silent in the absence of immune 
stimuli. Injury, the injection of bacteria, or their cell wall components can induce the 
expression of these genes. Thus, the upstream regions of the genes contain sequence 
motifs homologous to c«-regulatory elements found in the promoters of acute-phase 
response genes in mammals. The most prominent motifs are xB-like elements. These 
elements have been identified in the upstream region of several inducible genes for 
antibacterial factors in H. cecropia (Sun and Faye, 1992) Drosophila (Engstrom et al., 
1993; Kappler et ai, 1993), and S. peregrina (Kobayashi et al., 1993). Genes 
regulated under the xB-like motifs are known to be inducible by lipopolysaccharide, 
phorbol esters, or bacterial challenge.
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Insect defensins
Insect defensins were first isolated firom the dipteran insect S. peregrina 
(Matsuyama and Natori, 1988) and later firom Phormia terranovae (Lambert et at., 
1989). The peptides have many structural features in common with mammalian 
defensins. This is the reason these peptides are called insect defensins. The defensin 
peptides, like cecropins, are induced on injury and microbial penetration and released to 
the hemolymph of insects. The peptides are predominantly active against Gram- 
positive bacteria but have no activity against Gram-negative bacteria. The peptides are 
fairly distributed throughout insects and also reported in scorpions (Cociancich et al., 
1993). The peptides are 34-43 amino acids long, and contain six cysteines forming 
three disulfide bridges. The three-dimensional structure for the defensin A of P. 
terranovae showed the three distinct domains: a flexible N-terminal loop, a central 
amphipathic a-helix and a C-terminal antiparallel P-sheet (Bonmatin et al., 1992). This 
structural feature of insect defensins is different fi'om that of mammalian defensins, 
which consist solely of P-sheets.
Insect defensins are synthesized as preprodefensins. After cleavage of a signal 
peptide (23 residues) and processing a prosequence (29 residues), a mature peptide 
with C-terminal amidation is released into the hemolymph of insects.
Attacins
Attacins are inducible antibacterial polypeptides with M.W. around 20 kd. 
Although several attacins were isolated from the immune hemolymph of H. cecropia.
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their antibacterial spectra were limited showing activity only against E. coli. They 
contain a high number of glycine residues (Hultmark et al., 1983; Ando et al., 1987). 
Proline-rich peptides
Small, proline-rich peptides active against Gram-negative bacteria have been 
found in the hemolymph of immunized insects. Apidacins consist of 18 amino acids 
(Casteels et al., 1989), and abaecin consists of 34 residues (Casteels et al., 1990). 
They were all isolated from the hemolymph of immunized honey bees. Drosocin 
isolated from D. melanogaster is a 19-residue proline-rich peptide with three Pro-Arg- 
Pro repeats. Interestingly, drosocin is glycosylated and its activity is decreased without 
glycosylation (Butlet e/a/., 1993).
Antimicrobial peptides in frogs 
The frog skin has been known as an extraordinary source of biologically active 
peptides. These include hormones, neuropeptides and other agents that may not be 
found in mammalian systems (Eraspamer et al., 1985). In 1987, while they searched 
for the clue on the absence of local inflammation during the healing of surgical wounds 
in frogs, Zaslofif and his colleges discovered antimicrobial peptides from the skin of a 
frog, Xenopus laevis (Zasloff  ̂ 1987). Later on, similar peptides were isolated from the 
skin of different frogs (Gibson et a i, 1991; Simmaco et a i, 1991; Simmaco et ai, 
1993). These peptides are synthesized in the granular gland which stores large amount 
of biologically active peptides. They are believed to be involved in the defense of the 
naked skin of frogs against microorganisms.
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Antimicrobial peptides isolated from the skin of the African clawed frog, 
Xenopus laevis  ̂ were named magainin 1 and magainin 2 whose sequences differ in 
positions 10 and 22 (Zaslofr^ 1987). The magainins are basic (lysine-rich) and consist 
o f 23 amino acids. They have no cysteine residue and are thought to form an a-helix. 
They are active against many pathogens such as Gram-positive and Gram-negative 
bacteria, fungi, and protozoa. Recently, the identical magainin peptides were also 
isolated from the stomach of Xenopus (Moore et a/., 1991), indicating that Xenopus 
has the capacity to secrete antimicrobial peptides directly into the lumen of the stomach 
by a secretory mechanism.
Several related peptides were identified from the skin of X. lavis. These include 
PGLa, caerulein precursor fragments (CPFs), xenopsin precursor fragments (XPFs), 
and levitide precursor fragment (LPF) (Bevins and Zaslofif, 1990). These peptides 
consist of 21 to 27 amino acid residues and share a similar spectrum of antimicrobial 
activity with magainins. While there is no absolute consensus sequence, the sequences 
show limited sequence identity. However, they are all considered amphipathic a -  
helices. The cDNA for magainin shows that they are synthesized as prepropeptides. 
After proteolytic processing, mature peptides are stored in secretory vesicles. 
Following discharge, the mature peptides are cleaved into half peptides by the action of 
an endopeptidase, resulting in inactivation of peptides (Resnick et ai, 1991).
Antimicrobial peptides in mammals
The discovery in the past decade of various antimicrobial peptides originating 
from phagocytic cells in mammals has led to understanding their active involvement of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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protecting the host from invading microorganisms. Polymorphonuclear leukocyte 
^M N ) is non-dividing, short-lived phagocytic cells with granules containing a wide 
range of antimicrobial factors. Upon engulfrnent of microorganism, the granule then 
fuses with the vacuole to form a phagolysosome where the ingested microbe is killed by 
toxic oxidants or by peptides and proteins via nonoxidative mechanisms. When PMNs 
injure targets through antibody-dependent cell cytotoxicity (ADCC) the granular 
contents are delivered to the target cells by a secretory process called degranulation.
The presence of antimicrobial peptides in the granule had been described in 
rabbit and guinea pig PMNs in the 1960s (Zeya and Spitznagel, 1966). Those peptides 
were later purified from rabbit lung macrophages in 1980 (Patterson-Delafield et al., 
1980). Three years later, the first sequences were reported and the peptides were 
named defensins (Selsted et al., 1983). Defensins so far have been isolated from rabbit, 
guinea pig (Yamashita et al., 1989; Selsted and Harwig, 1987), rat (Eisenhauer et al.,
1989), cow (Selsted et al., 1993), human (Lehrer et al., 1993), and mouse (Ouelette et 
al., 1989). They consist of the largest group of antimicrobial peptides and are likely to 
occur in many mammalian species. Although most of defensins have been found in 
neutrophil granules, alveolar macrophage (rabbit) and intestinal Paneth cells in human 
and mouse were reported to produce defensins (Jones and Bevins, 1992; Selsted et al., 
1992). Defensins can be broadly divided into two groups: classical defensins and (3- 
defensins. In addition to the defensins, other antimicrobial peptides were discovered in 
bovine PMNs.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
12
Classical defensins
Classical defensins are found in most species including human, rabbit, guinea 
pig, and rat. Neutrophil granules, alveolar macrophages, and intestinal Paneth cells are 
the richest sources of classical defensins. These peptides are stored in the azurophil 
granules o f their circulating cells and make up more than S% o f the total protein in 
rabbit and human granulocytes. They contain 29 to 34 amino acid residues with a high 
content of Arg residues and form three intramolecular disulfide bridges. Their six 
cysteines are linked 1-6, 2-4, and 3-5. X-ray crystallography showed that classical 
defensin molecules consist of a triple-stranded antiparallel p-sheet stabilized by 
disulfide bonds (Hill et al., 1991). Classical defensins show a wide range of 
antimicrobial activity including Gram-positive and Gram-negative bacteria, 
mycobacteria, protozoa, some fimgi and enveloped viruses in vitro. However, when 
the peptides are used at higher concentrations, they can be cytotoxic to mammalian 
cells in vitro in the absence of serum (Lehrer et al., 1993).
The cDNAs for seven classical defensins (human HNP-1 and HNP-3; rabbit 
NP-1, NP-2, NP-3a, NP-4, and NP-5) have been cloned, and sequenced (Daher et al., 
1988; Ganz et al., 1989). The mature defensins are synthesized initially as 
preprodefensins. N-terminal 19 amino acid residues consist of a signal sequence for 
insertion into the endoplasmic reticulum and a prosequence containing 40-45 residues. 
The prosequence appears to target the peptides to the granules of phagocytic cells. 
The synthesis and post-translational processing for human defensins has been studied in 
different murine cell lines transduced with cDNA (Ganz et al., 1993). Proteolytic
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processing to mature defensins was seen in myeloid cells. In contrast, nonmyeloid cell 
lines failed to process the prodefensin, indicating that the enzymatic and transport 
machinery is required to process preprodefensin to mature defensin.
Most of the defensins so far described, are localized within hematopoietic cells 
where defensins are delivered to phagolysosomes and kill microorganisms 
intracellularly. Recently, data showed that epithelial cells are also a source of defensins 
(Jones and Bevins, 1992; Selsted et al., 1992; Eisenhauer et al., 1992). Intestinal 
defensins were described in mouse and human Paneth cells, granulated epithelial cells at 
the base of the mucosal crypt of the small intestine and proximal colon of many 
mammalian species. These enteric defensins appear to be localized in eosinophilic 
secretory granules of the Paneth cells and secreted into the lumen, providing the crypt 
with a local antibacterial niche that limits bacterial colonization and invasion of the 
small intestine. Their active secretion into the lumen distinguishes them from 
phagocyte defensins, which are normally targeted to intracellular granules.
P-defensIns
P-defensins have been isolated from bovine tracheal mucosa (Diamond et al., 
1991), bovine neutrophils (Selsted et al., 1993), and bovine tongue (Schonwetter et al., 
1995). They consist of 38-42 amino acid residues with sbc cysteines which are linked 
1-5, 2-4,and 3-6 to form three disulfide bridges (Tang and Selsted, 1993). Although 
the P-defensins resemble classical defensins in many ways such as their location, their 
amino acid composition, and their microbicidal activity, these two peptide groups are 
distinguished by their unique consensus sequences and the location of three disulfide
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bridges. In situ hybridization studies indicate that the bovine tracheal P-defensins 
(tracheal antinucrobial peptides, TAP) and the bovine lingual P-defensins (lingual 
antimicrobial peptide, LAP) are produced by epithelial cells (Diamond et a i, 1993; 
Schonwetter et a i, 1995). Furthermore, TAP-producing cells are not observed to 
possess organelles for TAP storage prior to release. Both peptides are believed to play 
a role in the host defense of epithelial tissue.
The cDNA for the TAP has been cloned, sequenced, and found to encode 64 
amino acids. The 38 carboxyl-terminal residues correspond to the mature TAP peptide 
and the N-terminal 26 residues consist of a preprosequence.
Proline- and Arginine-rich peptides
Mammalian neutrophils produce several antimicrobial peptides structually 
different from defensins. These peptides include Bac-5 and Bac-7 isolated from bovine 
neutrophils (Frank et al., 1990), and PR-39 from pig intestine (Agerberth et a i, 1991) 
and later identified in pig bone marrow cells (Storia et al., 1993). They have high 
contents o f proline and arginine residues consisting of more than 60% of the total 
amino acid residues. The Bac-5, and Bac-7 peptides contain 43 and 59 residues, 
respectively, and the PR-39 peptide contains 39 residues. The sequences of this group 
have several Pro-Arg-Pro and/or Arg-Pro-Pro repeats but show no sequence 
homology. These three peptides are primarily active against Gram-negative bacteria. 
Recently, using a PCR probe derived from the PR-39 gene, a putative human peptide 
antibiotic, FALL-39, was identified in human bone marrow and testis (Agerberth et al., 
1995).
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A common structural motif in antimicrobial peptides
Although the action mechanism o f antimicrobial peptides is not clearly 
understood, they are generally believed to interact with cell membranes, form 
membrane pores, and lyse cells. Thus, it is not surprising that most of the antimicrobial 
peptides discovered so far have many features in common. T h ^  are positively charged 
and have the ability to form amphipathic structures, either as a-helices or P-sheet. This 
common structural motif is believed to be important in understanding how the 
antimicrobial peptides bind to membranes and disrupt membrane function to kill cells.
Biological membranes are composed of a phospholipid bilayer as their basic 
structure unit. Phospholipids contain both hydrophobic and hydrophilic ends, which 
combine to form a two-dimensional sheet where the polar lipid heads face the aqueous 
surfaces and the fatty acyl chains are buried within the hydrophobic interior. These 
membranes, due to their composition of polar lipid heads, are negatively charged so 
that the positively charged peptides can bind to the surface of the membrane by 
electrostatic interactions. It was observed that an artificial, positive membrane surface 
led to repulsion of positively charged cecropin peptide (Christensen et a l, 1988). 
Although cell membranes contain a high proportion of proteins and a small amount of 
carbohydrate that also provide negative charge on the cell membrane, the major target 
o f peptides in the cell membrane is considered to be the phospholipid bilayer. This is 
based on the observation of membrane leakage on liposomes treated with antimicrobial 
peptides (Steiner et al., 1988).
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In general, antimicrobial peptides are known to be inserted into the membrane 
analogous to membrane channel proteins. These channels are formed by a cylinder-like 
structure through the membrane such that the hydrophobic side of the protein is 
exposed to the membrane lipids and the hydrophilic side lines up with the pore. As a 
result, membrane pores allow the passive flow of ions and small molecules across the 
phopholipid bilayer. This amphipathic nature of proteins or peptides is a basic 
structural motif of membrane channel proteins. In the case of a-helical peptides such 
as cecropins and magainins, the simplest way to demonstrate the amphipathy is to 
display amino acid sequence on an Edmundson a-helical wheel, where hydrophilic 
residues are found on one side of the wheel and hydrophobic residues are located 
completely on the opposite side (Schiflfer and Edmundson, 1967). In addition to 
amphipathy, a minimum length of a-helix is required to span at least 30 Â of 
phospholipid bilayer. In the a-helix, the distance between each amino acid residue is 
1.5 Â. Thus, a minimum of 20 residues is required to form a membrane-spanning a- 
helix. Sometimes, a peptide as short as 15 residues shows membrane-disrupting 
activity. It is suggested that two molecules may associate together as head-to-head or 
head-to-tail dimers to form transmembrane channels, or they form 3io-helices, where a 
15 amino acid peptide can be 30 A in length (Andreu et a l, 1992).
Design of synthetic antimicrobial peptides 
The synthesis of synthetic analog peptides was carried out to determine the 
importance of individual amino acids and to enhance the antimicrobial activity. This 
work has been attempted on peptides without disulfide bridges such as cecropins,
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magainins, and meiittin since cysteine-containing peptides such as defensins are difficult 
to chemically synthesize because of problems in making the correct disulfide bridges.
Cecropin analogs were designed with deletion, substitution or variable chain 
length. When cecropin A was substituted with all n-amino acids, the o-amino acid 
analog showed similar biophysical and antibacterial activities (Wade et a l, 1990), 
showing that the mechanism of action of cecropins does not involve a chiral receptor. 
When Leu-4 and Ile-8 in cecropin A were substituted with helix-breaking Pro residues, 
the antibacterial activity was lost (Andreu et ai, 1985), indicating the importance of the 
a-helical structure in the N-terminal region of the molecule. Generally, shortening the 
size of cecropin A resulted in analogs with reduced biological activity. An analog of 
cecropin B was designed with a drastic amino acid change but keeping the basic and 
amphipathic nature of the molecule (Fig. 1.1) (Jaynes et al, 1988). This analog showed 
good biological activity against various pathogens. This analog peptide demonstrates 
that the biological activity of antimicrobial peptides is dictated by their physical 
structure and not by their primary sequences. Hybrid peptides were designed 
incorporating parts of cecropin A and meiittin. One of these analogs, CA(1-13)M(1- 
13), was highly active against different bacteria and also acted against Plasmodium 
without lysing sheep red cells (Boman et a l, 1989b).
The synthesis of magainin analogs was done with relative ease since magainins 
contain only 23 amino acids. To see the minimum size requirement, maganin-2 was 
truncated fi"om the N-terminal end (Zasloff et al, 1988). While removal of the first 3 
amino acids retained some antimicrobial activity, subsequent removal of the 4th amino
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(D hydrophobic amino acids 
O  hydrophilic amino acids
Fig. 1.1. Amino acid sequences of cecropin B and a designed antimicrobial peptide, 
cecropin analog SI. An Edmundson helical wheel is drawn for cecropin analog SI 
whose N-terminal region shows the amphipatWc nature.
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acid, lysine, resulted in a substantial decrease o f activity. It was concluded that a 
minimum size, 20 amino acid residues, was necessary for the peptide to span the cell 
membrane. Several magainin analogs were synthesized to increase a-helicity by 
replacing helix-breaking Gly residues with Ala (Chen et al., 1988). These peptides 
increased antimicrobial activity, but there was a substantial increase in their ability to 
lyse red blood cells. Besalle et al. (1990) synthesized magainin analogs with additional 
Lys or Arg residues at either C- or N-terminus in order to increase the interaction of 
peptides with the negatively charged phospholipids. The analogs with 10 or 20 Lys or 
Arg showed increased antimicrobial activity. One of magainin analogs developed by 
Magainin Pharmaceuticals, Inc., MSI-78, was known to have a broad spectrum of 
activities against bacteria and fungi (Maloy and Kari, 1995). This peptide is being used 
in clinical trials for the treatment of skin and eye infections caused by microbial 
pathogens.
The use of baculovirus for foreign gene expression
Baculoviruses are one of the largest and most diverse of insect viruses with 
double-stranded DNA genomes of 88-153 kbp (Blissard, 1990). Due to their 
pathogenic nature for insects, this group of viruses has been studied and used for the 
control of insect pest populations (Wood and Granados, 1991). Recently, with the 
development of molecular biology, the baculovirus has become one of the most useful 
expression vectors for the production of foreign proteins in research and biotechnology 
(Luckow, 1993; Miller, 1993). Also, by equipping these viruses with more insecticidal
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genes, they have been greatly improved the viruses for use as biological pesticides 
(Tomalski and Miller, 1991; Stewart e/a/., 1991).
General biology of baculovirus
Baculoviruses are divided into three subgroups on the basis o f viral occlusion 
morphology. Subgroup A, the nuclear polyhedrosis viruses (NPVs), has many virions 
occluded within intranuclear protein crystals known as polyhedra. In this group, some 
viruses are found as singly enveloped nucleocapsids (SNPV), and others are as multiply 
enveloped nucleocapsids (MNPV). Subgroup B, the granulosis viruses (GVs), has a 
single virion occluded within a single small crystal called granule. Subgroup C consists 
of a small group of baculoviruses which have no occlusion body surrounding the 
virions. In nature, NPVs are found in plant foliage, plant debris, and soil. The virus- 
containing occlusion bodies are highly stable and protect the virions in the environment. 
The occlusion body is mainly composed of a 29 kd protein called polyhedra. When 
NPVs are ingested by insects, the inert polyhedra are subject to the high pH in the 
insect midgut and are dissolved. As a result, the infectious virions are released and 
infect susceptible midgut epithelial cells.
NPVs have a unique life cycle where two structually different but genetically 
identical virions are produced (Blissard and Rohrmann, 1990). The virions found in 
polyhedra are called polyhedra-derived virus (PDV), and the other form found in the 
hemolymph of infected insects is called budded virus (BV). After polyhedra are 
dissolved in the midgut, released PDV-phenotype virions enter the host cells by fusion 
of the virion envelope with microvilli of midgut epithelial cells. Nucleocapsids are then
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transported into the nucleus where uncoating and replication of viral DNA occur. 
Subsequently, some of progeny nucleocapsids are released from the nucleus and bud 
through the cytoplasmic membrane into the hemocoel. These budded viruses (BV) are 
equipped with the virus-encoded glycoprotein, gp64, on the membrane which is not 
detected in the PVD virions. The BV appear to be used for the systemic spread of 
virus to other cells. Other progeny nucleocapids are enveloped in the nucleus and 
occluded within polyhedra. These polyhedra are released into the environment afrer 
lysis of the host cells. The polyhedra provide the means for horizontal transmission of 
the virus among susceptible insects.
The expression of viral genes and DNA replication appear to occur in three 
consecutive events: early, late and hyperexpressed late genes. Early baculovirus genes 
are recognized by host cell RNA polymerase II and can be transcribed by uninfected 
cells. Late genes are transcribed from the late baculovirus ATAAG promoter only after 
viral DNA replication begins. Hyperexpressed late genes begin to be transcribed when 
late gene transcription declines at a very late time postinfection. The transcriptional 
level of hyper late genes remains high throughout the completion of the infection cycle.
Polyhedrin and p 10 are the products of hyperexpressed late genes. Polyhedrin 
is a 29 kd protein and the major component of the occlusion body, polyhedra. This 
protein is made of up to 18% of total alkali-soluble protein late in the infection stage. 
Its main function is to provide the virions with protection from the UV of sunlight. 
The other hyperexpressed gene product, PIO, is usually found with polyhedra, although 
its role in the assembly of the occlusion body is unclear. In recombinant baculovirus
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with plO genes mutated or deleted, the polyhedra are not properly associated with 
polyhedrin envelope ^ E )  in the nucleus and are readily disintegrated (Williams et al.,
1989). This physical sensitivity of polyhedra is believed to be due to the improper 
association of a polyhedrin envelope, suggesting that plO plays a role in the transport 
and attachment of the PE to polyhedra. Recently, these two proteins have received 
much attention for overproducing recombinant proteins because they are 
hyperexpressed and not essential for viral replication in cell culture.
Baculovirus expression system
The recent popular use of the baculovirus expression system is attributed to its 
advantages over other expression systems. This expression system, unlike bacterial 
expression systems, uses eukaryotic insect cells and has been reported to utilize post- 
translational modifications such as secretion, glycosylation, proteolytic cleavage, 
phosphorylation, and myristylation. With the use of polyhedrin or plO gene promoter, 
this system is expected to produce high levels of protein synthesis. Additionally, these 
genes are not essential for infection or replication and thus recombinant viruses can be 
propagated easily in cell culture. For the insertion of genes, the large baculovirus 
genome can accommodate a considerable size of foreign DNA. Finally, baculoviruses 
are noninfectious to vertebrates, meaning that the manipulation of bacuoviruses is quite 
safe in the laboratory.
To produce recombinant baculoviruses, a foreign gene is inserted into the virus 
under the control of a strong promoter, either the polyhedrin gene promoter or the p 10 
gene promoter. The most widely used baculovirus for the expression system is
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Autoff^apha califomica nuclear polyhedrosis virus (AcMNPV). Since the baculovirus 
genome is too big to manipulate as a plasmid-like vector, viral DNA containing the 
polyhedrin or plO genes is first inserted into a bacterial plasmid. This plasmid, transfer 
vector, is then used for cloning a foreign gene downstream of the promoter and 
delivering the gene into the baculovirus. In a homologous recombination event, the 
polyhedrin gene or plO gene in baculoviruses is replaced with the foreign gene in the 
transfer vector. As a result, recombinant viruses lack the polyhedrin gene or the plO 
gene depending on the gene on which the foreign gene is located. Homologous 
recombination between circular wild-type virus DNA and the transfer vector was 
known to occur at a low fi’equency, typically less than 1%. To increase the proportion 
of recombinant viruses, wild-type viral DNA was linearized and an essential portion of 
the 1629 open reading fi-ame downstream fi'om the polyhedrin gene was deleted. This 
modified wild-type viral DNA was observed to produce over 85% recombinant viruses, 
when coinfected with a transfer vector that complements the deletion (Kitts et ai, 
1990; Kitts and Possee, 1993).
For the selection of recombinant viruses, the baculovirus expression system 
uses a visual screening allowing them to be distinguished fi'om wild-type viruses. The 
polyhedrin protein is produced at very high levels in the nuclei of infected cells and 
forms occlusion bodies which can be easily seen with a light microscope. Therefore, 
recombinant viruses where the polyhedrin gene is replaced with a foreign gene appear 
as clear plaques in a plaque assay. However, this visual screening for a polyhedrin- 
negative phenotype requires considerable experience with the baculovirus system. A
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more improved approach involves the insertion of the lacZ gene upstream o f the 
polyhedrin promoter. Without screening occlusion-negative viruses, the ladL gene 
confers a blue plaque on the recombinant virus in which the foreign gene is under the 
control o f the polyhedrin promoter (Malard et al., 1990). However, for those viruses 
utilizing the p 10 promoter, the visual screening cannot be used because this gene 
product does not give a visible phenotype. In this case, the p 10 coding sequences can 
be replaced with a visual marker gene such as 3-galactosidase gene (Weyer et at.,
1990). When this virus is expressed in insect cells, this results in blue plaques on the 
chromogenic substrate X-gal. The next step is to cotransfect this viral DNA with a 
transfer vector where a foreign gene is under the control of the p 10 promoter and then 
select recombinant viruses with a white phenotype. Instead of using the phenotype 
screening, recombinant viruses can also be identified by DNA hybridization and 
polymerase chain reaction (PCR) amplification.
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CHAPTER TWO
DESIGN OF A CECROPIN ANALOG GENE AND ITS EXPRESSION IN A
BACULOVIRUS SYSTEM
Antimicrobial peptides have been discovered in many different sources such as 
insects (Boman, 1991; Morishima et al., 1990; Kylsten et al., 1990), frogs (Zaslofi^ 
1987), cows (Selsted et al., 1993), and humans (Lehrer et al., 1993). These peptides 
have a broad spectrum of biological activities against many pathogens including 
bacteria, fungi, enveloped viruses, and protozoa. They are believed to be part of the 
innate immune systems of diverse genera; their action does not require any antigenic 
specificity or memory as seen in adaptive immunity (Zasloff 1992). Indeed, all of the 
peptides kill pathogens in a relatively nonspecific manner by lysing their cell 
membranes. This common property o f their function is attributed to the common 
structural motif in their amino acid sequences. They are highly basic, and have 
potential to form amphipathic secondary structures like membrane chaimel proteins 
(Ojicius and Young, 1991). The basic peptides interact with the negatively charged 
cell membranes and, it is proposed, disrupt the membranes by forming pores in such a 
way that the hydrophobic side of amphipathic peptides is exposed to the membrane 
lipids and the other hydrophilic side lines up the pore.
The synthesis of analog peptides can be made by fulfilling the above structural 
motif for the purpose of understanding the mechanism of action and improving the 
antimicrobial activity. Various cecropin and magainin analogs have been synthesized 
by substitution and deletion of individual amino acids (Andreu et al., 1985; Zasloff et
25
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a/., 1988). Additionally, hybrid peptides were synthesized consisting of portions of 
cecropin A and meiittin (Boman et al., 1989b). Previously, a cecropin analog was 
designed and synthesized by maintaining the positively charged and amphipathic nature 
of cecropin B (Jaynes et al., 1988). Nineteen of the 35 amino acid residues of cecropin 
B were substituted in the analog peptide. For example, positively charged hydrophilic 
amino acids were replaced with other amino acids of similar character. When this 
peptide was tested on various pathogens it showed cytocidal effects on some protozoa 
such as Plasmodium falciparum and Trypanosoma cruzi as well as bacteriocidal 
effects.
With the development of recombinant DNA technology, the question arises as 
to whether a designed antimicrobial peptide could be expressed in a DNA expression 
system. The availability o f a gene for the peptide would be helpful not only for the 
accurate synthesis of the peptide but also for future applications on transgenic systems 
and gene therapy. It appears to be possible that some antimicrobial peptides can be 
directly used for topical application on skin infections or eye infections. However, the 
broad or systemic administration of peptides will not be done with ease because the 
peptides are susceptible to proteolytic enzymes and can be cytotoxic to host organisms. 
The use of genetic material, including appropriate target sequences, will help to induce 
the peptide in a specific site, where the expressed peptide can be used to kill pathogens. 
However, little information is available on how a bioactive, designed peptide is 
genetically expressed. It is suggested that basic studies need to be done on the 
usefulness of synthetic peptide genes before approaching practical use. This chapter
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describes the design of a cecropin analog SI gene and its expression in insect cells 
using a baculovirus vector. Two gene constructs were designed, and chemically 
synthesized; one consists of a gene encoding only mature peptide, and the other is a 
hybrid between the cecropin B preprosequence and the mature peptide-encoding gene. 




Synthesis and purification of the cecropin analog peptide, Shiva-1, was done as 
described before (Jaynes et at.,. 1988) with a little modification. In the modified 
peptide, the first two N-terminal amino acids (Met, Pro) of the original peptide were 
deleted and C-terminal glycine was amidated like a mature cecropin B. The new 
peptide was renamed cecropin analog SI.
Cells and viruses
Spodoptera Jrugiperda (Sf9) insect cells and Autographa califomica nuclear 
polyhedrosis virus (AcNPV) were obtained fi'om Invitrogen. The Sf9 cells were grown 
at ITC  in Grace’s insect medium supplemented with 10% fetal bovine serum 
(GibcoBRL). Plasmid pJVNhel (Vialard et al., 1990) and wild-type baculovirus were 
fi'om Invitogen.
Construction of cloninig vector pLPV9
Plasmid pUC19 (Yanisch-Perron et al., 1985) was digested with £coRI and the 
S' protruding ends were filled in with Klenow fi'agment of DNA polymerase I and
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ligated. Oligonucleotides having several restriction enzyme sites {Xbal, BspML, BglQ., 




The oligonucleotides were Idnased and annealed by heating at 90°C for 10 min and then 
cooled to room temperature. The oligonucleotides were inserted into Xbal and HindHl 
sites o f the plasmid pUC19 prepared as above. The final plasmid was named pLPV9. 
Synthesis of preprocecropin analog SI gene
Synthesis of a preprocecropin analog SI gene was done by fusing the 
preprosequence-encoding oligonucleotides (CE) of cecropin B (van Hofsten et al., 
1985) and the mature peptide (Sl)-encoding gene. The CE oligonucleotides were 
synthesized as four overlapping single stranded oligonucleotides (CE-1, 2, 3, and 4) as 
shown in Appendix. The CE-1 and CE-3 oligonucleotides form the coding strands, and 
the CE-2 and CE-4 oligonucleotides form the complementary strands. The 5' end of 
CE oligonucleotides were designed to have a Xbal site and the 3' end was blunt-ended. 
The CE oligonucleotides were kinased and annealed by heating single strands to 90°C 
for 10 min and then cooled to room temperature. The SI gene was excised using BglU 
and EcdBl fi'om plasmid pMON. Shiva-1 (Nagpala, 1990), and the fragment was 
inserted into the same enzyme sites of the plasmid pLPV9. The resulting plasmid 
pLPSl was digested with BsplsÆl, followed by mung-bean nuclease treatment and Xbal 
digestion. The CE oligonucleotides were inserted into the resulting plasmid. The final
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construct was named pCESl. The preprocecropin analog SI gene was sequenced by 
the chain-termination method (Sanger et al., 1977) using the Sequenase kit (U.S. 
biochemicals).
Construction of baculovirus transfer vectors pBSl and pBCESl
The SI gene in the plasmid pLPSl was excised using Xbal and Nhel, and the 
fragment was inserted into the Nhel site o f a baculovirus transfer vector pJVNhel. The 
orientation of the inserted gene was confirmed by restriction analysis. The resulting 
plasmid was named pBSl. Dot Xbal and ^ e l  cut of preprocecropin analog SI in the 
plasmid pCESl was inserted into the Nhel site of the transfer vector pJVNhel. The 
proper orientation was also confirmed by restriction analysis. The final construct was 
named pBCESl.
DNA transfections and plaque assays
Plasmids pBSl and pBCESl containing each cecropin analog SI gene were 
transfected into Sf9 cells together with wild-type viral DNA by using the calcium 
phosphate precipitation technique (Summers and Smith, 1987). Plaque assays were 
performed on culture plates (100 by 15 mm). Infected cells were overlaid with 1% 
agarose diluted with Grace’s insect medium containing 150 pg/ml X-gal.
Isolation of recombinant viruses
Plaques stained blue in the presence of X-gal were picked with Pasteur pipettes, 
placed in 1ml Grace’s insect medium, and filtered through 0.2 |om membrane. Plaque 
assays were again performed on Sf9 cells grown on culture dish. At least three rounds 
of plaque assays were done to generate recombinant virus free from wild-type virus.
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Isolated recombinant virus was amplified in Sf9 cells grown in 25 cm  ̂ culture flasks. 
The cultures were sufiSciently grown to detect the presence of occlusion body-forming 
wild-type virus.
Polymerase chain reaction
Approximately 2 x 10® Sf9 cells were infected with each recombinant virus or 
wild type virus. The cultures were grown 5-7 days until all cells were lysed. The viral 
supernatant was mixed with the same volume of a solution of 20% PEG (PEG 8,000) 
and 1 M NaCl. The mixture was incubated at room temperature for 30 min and 
centrifuged 10 min at 10,000 rpm to obtain a viral pellet. The pellet was resusupened 
with 200 pi of distilled water and 10 pi of Proteinase K (10 mg/ml), and incubated at 
50°C for 3 hrs. The viral DNA was obtained after phenol/chloroform extraction and 
precipitation with 100% EtOH. PCR amplification was carried out using standard 
protocols using a Perkin-Elmer thermal cycler (Cetus). Initial dénaturation was at 
94°C, 20 cycles of amplifications were done by cycling 1 min at 94“C, 2 min at 55“C, 
and 5 min at 72°C. For amplification of inserted genes, the two oligonuclotides were 




Six hundred microliters of chemically synthesized 81 peptide, dissolved at 1 
mg/ml in distilled water, were added dropwise to 1 mg of keyhole limpet hemocyanin 
(Sigma) dissolved in 1 ml distilled water. The mixture formed a cloudy precipitate
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without any coupling agent and the cloudy solution was mixed with Ribi adjuvant 
(Ribi). A New Zealand rabbit was immunized by intradermal, and subcutaneous 
injection with 700 jil of the mixture and boosted two weeks later.
Indirect ELISA
To test for antibody production, each well of ELISA plates was coated with 
100 pi of 2 pg/ml antigen solution in 0.05 M sodium carbonate buffer, pH 9.6 and 
incubated overnight 4“C. Plates were washed three times with phosphate buffered 
saline containing 0.05% (v/v) Tween 20 (PBST). Different dilutions of antiserum 
diluted in PBST were added to the wells and incubated 1.5 hrs at room temperature. 
After washing three times with PBST, the plates were incubated 1.5 hrs with 100 pi of 
alkaline phosphatase-conjugated anti-rabbit IgG (KPL) diluted 1/1000 in PBST. The 
plates were washed three times with PBST and color was developed by adding 100 pi 
of substrate buffer containing 1 mg/ml p-nitrophenyl phosphate, 10% diethanolamine, 
and 5 mM MgCh, pH 9.8. The absorbance of color was read at 405 nm in a microplate 
reader.
SDS-polyacrylamide gel electrophoresis
Lysates of Sf9 cells and culture fluids were subjected to electrophoresis 
described by Laemmli (1970). In order to detect low molecular weight peptides, the 
electrophoresis was done on 20% SDS-PAGE gels modified by Giulian et a/. (1985). 
In this system, the gel consisted of modified acrylamide/bisacrylamide ratios for a 
separating gel (20% T, 0.5% C) and a stacking gel (10% T, 4.8% C), and 10% glycerol 
was added in the gel matrix. The stacking gel used standard 0.125 M Tris at pH 6.8
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while the separating gel used 0.7 M Tris at pH 9.3. The Icm-thick gel was run at 16 
mA/gel for the stacking gel. Then, the current was adjusted to 20 mA/gel. 
Immunoblots
The separated proteins were electrophoretically transferred to nitrocellulose 
membranes (Schleicher & Schuell) in Towbin buffer (Towbin et al., 1979) containing 
0.192 M glycine, 25 mM Tris, and 20% (v/v) methanol, pH 8.5. The membranes were 
blocked with 5% heat inactivated goat serum in phosphate buffered saline (PBS) 
containing 0.05% Tween 20 for 30 min. After three washes with PBS a 1:200 dilution 
of rabbit anti-cecropin analog SI antiserum was added, incubated for 1.5 hrs, and 
followed by goat anti-rabbit IgG-peroxidase conjugate (KPL) for another 1.5 hrs. The 
membranes were developed with 4-chloro-1 -naphthol (Sigma), and finally rinsed with 
distilled water.
Immunofluorescent staining
Cultured Sf9 cells separately infected with each recombinant virus were grown 
for 2 days, washed twice with PBS. The cells were resuspended with PBS and 100 pi 
of the cell suspension was mounted on a microscope slide by cytocentrifiigation. The 
cells were fixed in cold acetone for 20 min and air-dried. The fixed cells were 
incubated 1.5 hrs with a 1:200 dilution of rabbit anti-cecropin analog SI antiserum. 
After PBS washing the cells were incubated 1.5 hrs with 1:100 goat anti-rabbit IgG 
conjugated fluorescein isothiocyanate (FITC) obtained from KPL.
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Antibacterial assays
E. coli DH5a cells were cultured overnight at 37°C in LB broth, and 
subcultured by adding 1 ml of the culture to 99 ml of fresh LB broth. The cells were 
grown to an ODeoo of 0.4 to 0.5, centrifuged, and washed twice with assay buffer (10 
mM phosphate buffer, pH 7.0). The cells were resuspended in assay buffer at an ODgoo 
of 0.4 and diluted 10 times with the buffer. For the antibacterial assays, 100 pi of cells 
were mixed with 100 pi of cecropin analog SI peptides (40 pg/ml) and 100 pi of each 
dilution o f fetal bovine serum. The final assay culture was brought to 1 ml with assay 
buffer and incubated at 3TC with gentle shaking. At time intervals (0, 20, 60 min), the 
cells were collected, diluted 10*̂  to 10'*, and plated on LB agar media.
Results
Characterization of anti-cecropin analog SI antiserum
Anti-cecropin analog SI antiserum was developed using keyhole limpet 
hemocyanin as a carrier protein. Cecropin analog SI peptides were highly soluble in 
water, but the peptide formed a cloudy precipitate with increasing amounts of keyhole 
limpet hemocyanin. This precipitation was not observed in cecropin B, where a mixed 
solution of cecropin B and keyhole limpet hemocyanin remained clear. When another 
common carrier protein, bovine serum albumin, was used, neither cecropin analog SI 
or cecropin B formed any precipitate. From this observation, it appears that the analog 
peptide is biophysically different from cecropin B, although there is 46% sequence 
similarity between these two peptides.
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The cloudy mixture of cecropin analog SI and keyhole limpet hemocyanin 
appeared to induce a better antibody titer. When the analog peptide alone was used to 
immunize two rabbits, no antibody titer was detected in any of the rabbits. The cloudy 
mixture, however, induced at least 50,000 antibody titer for the analog peptide in 
indirect ELISA method (Fig. 2.1). Fig. 2.1 also shows a cross-reaction of anti- 
cecropin analog SI antiserum with cecropin B. However, the cross-reaction was not 
believed to occur by sequence similarity between the two peptides. Anti-cecropin B 
antiserum, which was developed using only cecropin B peptides as immunogens 
(Destefano-Beltran, 1991), showed little cross-reactivity with the analog peptide (Fig. 
2.2). Despite 46% sequence similarity, the analog peptide is not that much 
immunologically related with cecropin B.
Synthesis of preprocecropin analog SI gene
Plasmid pLPV9 was designed for the purpose of cloning genes into a 
baculovirus transfer vector and for constructing a hybrid gene between the cecropin B 
preprosequence and the mature 81 peptide-encoding gene (Fig. 2.3). The Xbal and 
Nhel sites in the pLPV9 allowed genes to be easily cloned into a unique Nhel cloning 
site in the baculovirus transfer vector pJVNhel. The hybrid gene was intended to have 
a gene structure as close as possible to the preprocecropin B gene. Since the cecropin 
B preprosequence was fused to the peptide-encoding gene, it was necessary to delete 
nucleotides at the S' flanking region of the gene. This was done by the combination of 
BspNO. and mung-bean nuclease digestion. The 81 gene, after cut out with BglU and 
£coRI in plasmid pMONS30.Shiva-1, produced S'-GATCTACCATG- at the BglU site













Fig. 2.1. Indirect ELISA assays for titration of rabbit anti-cecropin analog SI 
antiserum. Each antigen (0.2 pg/well) was incubated with 4-foId serial dilutions of 
antiserum. The absorbance was read at 405 nm.














Fig. 2.2. Indirect ELISA assays for titration of rabbit anti-cecropin B antiserum. Each 
antigen (0.2 pg/well) coated on a microplate was incubated with 4-fold serial dilutions 
of antiserum. The absorbance was read at 405 nm.











I EcoRI/Menow + dNTP 
































-g a la c to s ld a se




analog S I T







Fig. 2.3. Construction of recombinant baculovirus transfer vectors p3Sl and pBCESl. 
Plasmid pLPV9 was constructed by replacing restriction sites in pUC19. The vector 
pBSl was constructed by inserting the 81 peptide-encoding gene into a unique Nhel 
site of pJVNhel. A hybrid gene, preprocecropin analog 81, was made by fusing the 81 
peptide-encoding region with the preprosequence-encodlng oligonucleotides (CE) of 
cecropin B. The Xbal-Nhel fragment of pCESlwas inserted into the Nhel site of 
pJVNhel to form pBCESl.
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with ATG as a translational initiation codon for the gene. The digestion in
pLPSl created 5'-CT ACC ATG- with S'-CTAC protruding, and the mung-bean 
nuclease digested the protruding nucleotides (ÇTAQ. The digestion left the 5' end of 
the sequence S'-CATG- This was possible because the cut site of is 4 and 8 
base pairs away from the recognition site. The cecropin B preprosequence, with a 
Xbal site located at the 5' end, was ligated to the 5-CATG- of the resulting pLPSl. 
Although this design did not result in a correct prosequence as in preprocecropin B, the 
use o f^ ^ M I and mung-bean nuclease could change several codons which might create 
an unusual prosequence.
The preprocecropin SI gene was sequenced (Fig. 2.4). While the prosequence 
of cecropin B was reported as -AP-EP- where the dipeptide was sequentially cleaved 
by a dipeptidyl aminopeptidase (Boman et al., 1989a), the prosequence of 
preprocecropin analog SI in Fig. 2.4 shows the modified sites (-AP-DMP-) for the 
enzyme. This was attributed to the difhculty of modifying a translational initiation 
codon (ATG) since ACC nucleotides were located before the ATG codon as a Kozak 
sequence (Kozak et al., 1987) in the SI peptide-encoding gene.
Identification of recombinant viruses
Recombinant viruses each carrying a gene construct were produced in vivo by 
homologous recombination using cotransfection of Sf9 cells with wild-type viral DNA 
and each transfer vector DNA, respectively. The transfer vector carried a |3- 
galactosidase gene directed under the PIO promoter of Autographa califomica nuclear 
polyhedrosis virus within recombination regions, and thus recombinant viral selection
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ACC ATG AAC IT T  TCT AGO ATC TTC TTT TTC 30
M N F S R I F F  F
GTG TTC GCT CTT GTT CTC GCC TTG TCC ACT so
V f a l v l a l s  t
GTG TCT GCC GCT CCT GAC ATG CCG CG C TGG so
V S A ^  A P D M P R W
CGT CTG TTC CGC CGT ATC GAC CGT GTT GGC 120
R L F R R I D R V G
AAA CAG ATC AAA CAG GGT ATC CTG CGT GCT «0
K Q I K Q G I L R A
GGC CCG GCT ATC GCT CTG GTT GGC GAC GCC iso
G P A I A L V G D A
CG C GCA GTT GGT TGA iss
R A V G
Fig. 2.4. Nucleotide sequence of preprocecropin analog SI. The nucleotide sequence 
of preprocecropin analog SI gene with deduced amino acid sequence is shown. The 
cleavage site of cecropin B signal peptide by a signal peptidase is shown by a closed 
triangle. The amino acid sequence of designed cecropin analog SI is underlined.
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was done by picking up blue colonies on X-gal containing agar plates until there was 
no occlusion body-forming wild type virus. To identify each gene construct from the 
recombinant viruses, viral DNA was purified and PCR was done using two primers for 
the untranslated regions o f the polyhedron gene. One forward primer starts at -44 of 
the translation start site o f the gene and the other reverse primer at +794. These two 
primers made 838 bps PCR products for a wild type virus shown in lane 2 of Fig.2.5. 
In the case of recombinant viruses, the transfer vector pJVNhel was modified at the 3' 
region of the polyhedrin promoter, in which DNA size was shrunk by 128 bps with the 
translation initiation codon deleted (Vialard et a/., 1990). Thus, for each recombinant 
virus, the two primers made 917 bps PCR products in the pBCESl recombinant virus 
and 854 bps in the pBSl shown in lane 3 and 4 of Fig. 2.5, respectively. The size 
difference of PCR products between wild-type virus and pBSl recombinant virus was 
so small that these two viruses could not be identified in the PCR method followed by 
gel electrophoresis. Instead, recombinant viruses were able to be distinguished from 
the wild-type virus by lack of occulsion bodies visible with a light microscope. 
Identification of cecropin analog SI peptide expression
Expression of cecropin analog SI peptide in the baculovirus system was 
determined using SDS-PAGE, immunoblots, and immunofluoresent labeling of Sf9 
cells. The Sf9 cells infected with wild-type or recombinant baculoviruses at a 
multiplicity of infection (MOI) of 50 plaque-forming units/cell were harvested at 72 hrs 
postinfection. The resulting cell pellets were resuspended with 1/10 volume of distilled 
water and homogenized through a syringe needle. In the Coomassie blue-stained gel
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1 2  3 4
Fig. 2.5. Agarose gel analysis of PCR products obtained from Sf9 cells infected with 
wild-type virus and recombinant viruses pBCESI and pBSl. The amplified DNA 
fragments were applied on an 1% agarose gel and the gel was run at 100 volts. Lane 1, 
1 Kb DNA ladder, lane 2, PCR products from wild-type virus; lane 3, PCR products 
from recombinant virus pBCESI; lane 4, PCR products from recombinant virus pBSl.
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^ ig . 2.6), a cecropin analog SI peptide-specific band could not be dififerentiated fi-om 
wild-type infected and recombinant virus-infected sample preparations. The separated 
proteins were transferred onto a nitrocellulose membrane and were immunostained 
with rabbit anti-cecropin analog SI antibody (Fig. 2.7). The peptide band was detected 
in both cell lysate and culture medium fi*om the recombinant virus pBCESI. However, 
no peptide band was detected in either the recombinant virus pBSl or the wild-type 
virus. Since cecropin analog SI in the pBSI construct was designed to be expressed as 
cytoplasmic peptides the expression was further examined by labeling the S 8  cells with 
immunofluorescence (Fig.2.8). The strong fluorescent staining was detected only in 
pCESl-infected Sf9 cells, but not in pB SI-infected cells. No fluorescence was 
observed in wild-type infected cells, either. These results suggest that proteolytic 
enzymes degrade the analog peptide in the cytoplasm.
The expressed peptide appeared slightly larger than a 35 amino acid cecropin 
analog SI peptide (Fig. 2.7), meaning that Sf9 cells cleaved the signal peptide but didn't 
process the modified prosequence (-AP-DMP-). The use of cecropin B 
preprosequence was described in the secretion of proteins in plants, where the signal 
sequence of cecropin B was processed but the prosequence was not cleaved (Denecke 
et a i, 1990). In the following chapter, cecropin B is expressed as procecropin B in Sf9 
cells using a baculovirus vector.
Stable expression of cecropin analog 81 peptide
Figure 2.9 shows the time course of cecropin analog 81 peptide expression in 
the pBCESI recombinant virus-infected Sf9 cells. The cells initially expressed small









Fig. 2.6. Polyacrylamide gel electrophoretic analysis of proteins expressed in Sf9 cells 
infected with the recombinant baculoviruses pBSl and pBCESI. Sf9 cell lysates and 
culture medium at 72 hrs postinfection were both separated on 20% SDS-PAGE and 
stained with Coomassie blue. Lane 1, prestained molecular weight markers; lane 2, 
cecropin analog SI (1 |ig); lane 3 & 6, wild-type virus-infected S9 cells and culture 
medium; lane 4 & 7, pBCES 1 recombinant virus-infected Sf9 cells and culture medium; 
lane 5 & 8, pBSl recombinant virus-infected Sf9 cells and culture medium.
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Fig. 2.7. Immunoblot analysis of peptides expressed in Sf9 ceils infected with the 
recombinant baculoviruses pBSl and pBCESI. After electrophoresis, the proteins 
were transferred onto nitrocellulose membranes and immunostained with anti-cecropin 
analog SI antiserum. Lane 1, prestained molecular weight markers; lane 2, cecropin 
analog SI (0.2 ng); lane 3 & 6, wild-type virus-infected S© cells and culture medium; 
lane 4 & 7, pBCES 1 recombinant virus-infected S© cells and culture medium; lane 5 & 
lane 8, pBSl recombinant virus-infected S© cells and culture medium.
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B
Fig. 2.8. Iinmunofluorescent labeling of S 0  cells infected with recombinant viruses 
using anti-cecropin analog SI antibodies. A, S© cells infected with recombinant virus 
pBCESI; B, S© cells infected with recombinant virus pBSl.
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Fig. 2.9. Time course of expression in pBCESI recombinant virus-infected Sf9 cells. 
Sf9 cells were infected with the virus at an MOI of 50. The expressed peptides were 
detected in immunoblots. Lanes 2-6 show cell lysates harvested at 24 hrs, 48 hrs, 72 
hrs, 96 hrs, and 120 hrs postinfection, respectively; lanes 7-11 were loaded with the 
corresponding culture medium. Lane 1 shows prestained molecular weight markers.
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amounts o f the analog peptide by 24 hrs postinfection. Maximum expression was 
reached in the ceils between 48 hrs and 72 hrs postinfection. The peptide was seen at 
48 hrs postinfection in the culture medium and consistently throughout the remainder 
of the experiment. The decrease of expression in the cells aAer three days was caused 
by loss of cells from viral lysis, not by degradation of the expressed analog peptide. At 
48 hrs postinfection, two distinct analog peptide bands appeared in the cells. Band A 
appeared slightly in the cells at 24 hrs postinfection and band B followed at 48 hrs 
postinfection. Although band B seemed to be secreted slightly in the culture medium at 
72 hrs postinfection, most of band B expression appeared in the cells. The appearance 
of band B in the culture medium was believed to be caused by lysis of recombinant 
virus-infected Sf9 cells, but not by secretion. From this result, preprocecropin analog 
SI peptide is believed to be cleaved by a signal peptidase and its propeptide is secreted 
into the culture medium (band A). In the cells, the propeptide undergoes another 
posttranslational modification and its product (band B) is believed to stay or be 
targeted to some organelles. At this point, it is not clear how the preprocecropin 
analog SI is processed except for the signal peptide since its amino acid sequence is 
artificially designed and uncharacterized. While the modified prosequence (-AP-DMP-) 
has a site (-AP-) to be cleaved by a dipeptidyl aminopeptidase the modification is not 
believed to be processed by the enzyme. The following chapter shows that the Sf9 cell 
does not have this enzyme and cecropin B is expressed as a single band of procecropin 
B.
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Inhibition of antibacterial activity of cecropin analog SI by fetal bovine serum
To determine the effect of fetal bovine serum on cecropin analog SI activity, E. 
coli DHSa cells were incubated with the peptide and serum, simultaneously (Fig. 2.10). 
In the absence of serum, the peptide killed approximately 10® cells in 20 min when 
tested at 4 pg/ml. However, its activity was greatly inhibited in the presence of serum. 
Although proteolytic enzymes in serum may degrade the peptide and inhibit the 
activity, no degradation o f the peptide was observed in serum.
Discussion
The experiments described in this chapter demonstrate the design and 
expression of a synthetic gene encoding cecropin analog SI peptide in the baculovirus 
expression system. Two gene constructs were made in which one was designed for 
expression in the cytoplasm, and the other as a secretory peptide. The peptide 
expression was detected in the recombinant virus pBCESI but not in the recombinant 
virus pBSl which lacked a leader sequence. Any expression of peptide by the pBSl 
virus, if it occurred at all, was below the sensitivity level of peroxidase-based 
immunoblots or immunofluorescence. The baculovirus expression system generally 
expresses high amounts o f cytoplasmic proteins but low amounts of secretory proteins 
(Jarvis et al., 1993). Thus, the failure of peptide expression using pBSl may be 
attributed to instability o f the peptide in the cytoplasm and subsequent degradation by 
proteolytic enzymes. However, this does not explain the stable expression of the 
peptide in the culture medium. Baculovirus-infected Sf9 cells showed lysis by viral












Fig. 2.10. Antibacterial assays of cecropin SI peptide against E. coli DH5a in the 
presence of fetal bovine serum. Mid-Iog-phase K  coli cells (10^ CFU/ml) were 
incubated with 4 pg/ml of the peptide and various concentrations of FBS in 10 mM 
sodium phosphate buffer (pH 7.4) for.60 min at ST’C.
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infection at 48 hrs infection and subsequently released the cytoplasmic contents from 
the cells. In another study, the sarcotoxin A could be detected in the baculovirus 
system only afrer adding protease inhibitors in culture medium (Yamada et al., 1990). 
The stable expression of peptide in SG cells might be possible If serum proteins or 
components bound to or aggregated with the expressed peptide. Fetal bovine serum 
appeared to inhibit the antibacterial activity of chemically synthesized cecropin analog 
SI peptides by aggregating with the peptides. Also, it was observed that the pBCESI 
virus-infected culture medium lacked antibacterial activity against E. coli. Although 
several factors such as low expression and lack of prosequence processing could 
explain the lack of activity in the culture medium, the expressed peptide appeared to 
remain aggregated with serum.
Time course expression revealed that there might be another post-translational 
modification after cleavage of the signal peptide. Band A is believed to be the 
propeptide processed by a signal peptidase since it appears early in cells and in the 
medium (Fig. 2.9). The appearance of band B indicates that the propeptide (band A) is 
further cleaved proteolytically. While proteolytic processing at double basic residues 
has been noted for influenza hemagglutinin (Kuroda et al., 1986) and proattacin 
(Gunne et al., 1990) in Sf9 cells, band B is not thought to be a product after cleavage 
at basic residues. The SI peptide has Arg-Arg residues in the middle of peptide 
sequence, so that the cleavage would produce a low size band B. Also, if it was caused 
by proteolytic degradation, band B should appear together with band A both in Sf9
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cells and in the culture medium. This was seen in the expression of proattacin in Sf9 
cells, where proattacin and its degradative product were seen simultaneously in the 
cells and in the culture medium (Gunne et al., 1990). In Fig. 2.9, most of band B was 
seen in the cells and later in the medium where its appearance was believed to be 
caused by viral lysis of Sf9 cells. It seems likely that band B remains in the cells. Post­
translational processing of preprodefensin showed that propeptides, without further 
processing, were secreted mio the medium. Then, proteolytic removal of prosequence 
led mature defensins to be stored in cytoplasmic granules (Ganz et al., 1993).
From the present study, a designed antimicrobial peptide can be expressed in a 
baculovirus system. Antimicrobial peptides are easily designed and modified so their 
effects on pathogens can be improved. The utilization of in vivo expression for 
peptides can provide an effective way to fight pathogens through gene therapy or 
transgenic systems. However, several aspects should be considered in utilizing 
designed genes. First, gene products may not have to be secreted constitutively. Low 
levels of constitutively synthesized and secreted peptides may not be desirable. The 
expressed peptide may end up binding host factors or degrading due to its random 
structure before reaching pathogens as reported in the expression of cecropin B in 
transgenic plants (AUefs et al., 1995; Florack et al., 1995). An inducible gene structure 
such as the secretion of cecropins in the hemolymph of Hyalophora cecropia may be 
more effective against pathogens. Second, as in the production of mammalian 
defensins in granules of the neutrophil cells (Ganz et al., 1993; Cuoto et al., 1994), 
expressed peptides could be designed to be targeted to vesicles of phagocytic cells.
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which helps prevent peptide degradation or binding to extraneous host factors, and 
provides effective killing of intracellular pathogens in phagocytic cells without 
damaging the host cell.
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CHAPTER THREE
EXPRESSION OF CECROPIN B IN SF9 CELLS USING A BACULOVIRUS
VECTOR
Cecropins are antibacterial peptides originally detected in the hemolymph of 
giant silkmoth, Hyalophora cecropia, after a bacterial challenge (Hultmark et at., 1980; 
Steiner et al., 1981). Since this initial discovery, many inducible antibacterial peptides 
have been isolated from many insect species including the flesh fly Sarcophaga (Okada 
and Natori, 1985), the silkworm Bombyx (Morishima et al., 1990), the tobacco 
homworm Manduca (Dickinson et al., 1988), and the fruit fly Drosophila (Kylsten et 
al., 1990). Although a cecropin-like peptide has been described in pig intestine (Lee et 
al., 1989), cecropins are principally produced in insects. In the cecropia moth, three 
cecropins A  B, and D have been identified and range in size from 35 to 37 amino acid 
residues. Cecropins A and B are highly active against a broad spectrum of bacteria 
while cecropin D shows activity against only a limited number of Gram-negative 
bacteria (Boman and Hultmark, 1987). The N-terminal regions of cecropins A and B 
are strongly basic due to the presence of lysine and arginine and have the potential to 
form an amphipathic a-helix. On the other hand, the C-terminal halves are less charged 
and more hydrophobic. One proposed action mechanism of cecropins is that the 
positively charged N-terminal regions bind the negatively charged membrane, while the 
C-terminal regions insert into the membrane. Subsequently, the rearrangement of 
peptides occurs in the membrane where a channel is formed by the association of N- 
terminal helices (Christensen et al., 1988).
53
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From analysis of cDNA sequences, cecropia cecropins are made as precursor 
proteins, preprocecropins, of 62-64 residues (van Hofsten et a i, 1985). These 
precursors undergo several post-translational modifications to form mature cecropins. 
The first step is a signal peptidase, which cleaves the N-terminal 22 residues. The 
resulting procecropins are known to be fiuther processed by a dipeptidyl 
aminopeptidase which removes the dipeptides Ala-Pro and Glu-Pro in two steps. The 
final modification is at the C-terminal end, where the glycine residue is enzymatically 
cleaved, resulting in the conversion of the next-to-last residue to a C-terminal amidated 
form (Boman et a i, 1989a).
Previously, several attempts have been made to express the cecropin peptides in 
different expression systems, but the results were inconclusive. The expression of 
cecropin A has been observed in Trichoplusia ni larvae using a baculovirus vector, but 
not in S© cells (Hellers et a i, 1991). In the same expression system, a cecropin-like 
peptide, sarcotoxin lA, was expressed and detected in cell culture only after adding 
protease inhibitors in culture medium (Yamada et a i, 1990). Their results were quite 
contradictory to the observation in chapter 2, where cecropin analog SI peptides were 
stably expressed in the baculovirus expression system. The conflicting results have also 
been described in transgenic plants encoding cecropin B. Jaynes et a i (1993) found 
that transgenic tobacco and potato plants encoding cecropin B showed delayed 
symptom development after inoculation with Pseudomonas solanacearum. However, 
other studies found that resistance in transgenic plants was not altered (Hightower et 
a i, 1994; Florack e /a/., 1995; Allefse/nr/., 1995).
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In this chapter, the expression of cecropin B in an insect expression system will 
be explored. This study will help the future use of cecropin genes. Here, a chemically 
synthesized preprocecropin B gene is inserted into Autographa califomica nuclear 




Synthesis and purification of cecropin B was performed in the Department of 
Chemistry at LSU essentially as described (van Hofsten et a i, 1985). Cecropin analog 
SI was used as prepared in chapter 2. Cecropin A was purchased fi*om Sigma 
Chemical Co. All peptides were resuspended in distilled water at 1 mg/ml.
Cells and viruses
Spodoptera frugiperda (Sf9) insect cells were grown in Grace’s insect medium 
supplemented with 10% fetal bovine serum (GibcoBRL) and gentamycin sulfate (50 
pg/ml). Autographa califomica nuclear polyhedrosis virus (AcNPV) and plasmid 
pJVNhel were obtained fi-om Invitrogen.
Synthesis of preprocecropin B gene
Synthesis o f a preprocecropin B gene was done by fusing the preprosequence- 
encoding oligonucleotides (CE) of cecropin B with the mature cecropin B peptide- 
encoding gene. The synthesis of the CE sequence was described in chapter 2. The 
mature peptide-encoding gene was cut out of plasmid pDB37 (Destefano-Beltran, 
1991) with BglQ. and £coRI. The fi-agment was inserted into the same enzyme sites in
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plasmid pLPV9 (chapter 2). The resulting plasmid pLPB37 was digested with ^^M I, 
followed by mung-bean nuclease treatment and Xbal digestion. The CE sequence was 
inserted into the resulting plasmid. The final construct was named pCE37. The 
preprocecropin B was sequenced by the chain-termination method (Sanger et al., 1977) 
using the Sequenase kit (U.S. Biochemicals).
Construction of recombinant transfer vector pBCE37
The Xbal and Nhel cut of the preprocecropin B gene in pCE37 was inserted 
into the Miel site of the transfer vector pJVNhel (Vialard et a l, 1990). Restriction 
analysis was done to determine the proper orientation of the cloned gene. The right 
construct was selected and named pBCE37. The plasmid was cotransfected into Sf9 
cells along with wild-type AcNPV viral DNA using the calcium phosphate transfection 
procedure (Summers and Smith, 1987). Recombinant virus (designated pBCESI) was 
identified and purified by visual screening for formation of blue plaques as described in 
chapter 2.
Polymerase chain reaction
Sf9 cells infected with pBCE37 recombinant virus or wild-type virus were 
grown for 5-7 days. Each type of viral DNA was isolated and polymerase chain 
reaction (PCR) was done as described in chapter 2.
SDS-polyacrylamide gel electrophoresis and immunoblots
Sf9 cell lysates and culture fluids were subjected to electrophoresis described in 
chapter 2. After electrophoresis, the gel was stained with Coomassie blue or 
immunostained as described in chapter 2. For immunoblots, separated proteins were
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incubated with a 1:200 dilution of rabbit anti-cecropin B antiserum prepared previously 
(Destefano-Beltran, 1991).
Preparation of tobacco leaf extracts
Tobacco leaf tissue (200 mg) was frozen in liquid nitrogen, homogenized in a 
mortar and mixed with 2 ml of protein extract buffer (50 mM Tris, pH 7.5, 10 mM 3- 
mercaptoethanol). The extract was centrifuged 10 min at 10,000 rpm. The 
supernatant was filtered through 0.2 |im membrane.
Antibacterial assays
The assays were done essentially as described in chapter 2. For the efrect of 
insect hemolymph on cecropin B, pupae of Hyalophora cecropia were obtained from 
Ward’s Natural Science Ltd. Hemolymph was collected in tubes using a syringe 
needle, centrifuged, and filtered through 0.2 pm membrane. Hemolymph was kept 
frozen before use.
Results
Characterization of anti-cecropin B antibody
Indirect ELISA was performed in order to determine the cross-reactivity of 
anti-cecropin B antiserum with similar peptides. Serially diluted anti-cecropin B 
antiserum was incubated with cecropin B, cecropin A, and cecropin analog SI coated 
on a microplate. While the antiserum reacted with cecropin B up to 1:15,000 serum 
dilution in 20 min (Fig. 3.1), it also showed cross-reaction with cecropin A and 
cecropin analog SI. When preimmunized rabbit serum was incubated with these 
antigens, no cross-reaction was observed. Thus, it was believed that the cross-reaction

















Fig. 3.1. Indirect ELISA assay to determine the cross-reactivity o f anti-cecropin B 
against various antigens. Each antigen (0.2 pg/well) coated on a microplate was 
incubated with 4-fold serial dilutions of antiserum. The absorbance was read at 405
nm.
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was caused by sequence similarity of cecropin B with cecropin A and cecropin analog 
SI. The sequence similarity is 69% between cecropin B and cecropin A  and 46% 
between cecropin B and cecropin analog SI. The cross-reactivity of antiserum was not 
as high as expected in the sequence similarity. However, Fig. 3.1 shows a cross 
relationship between the cross-reactivity of antiserum and the sequence similarity. 
Although the anti-cecropin B antiserum cross-reacted with cecropin analog SI, it did 
not recognize the cecropin analog SI in immunoblots.
Synthesis of preprocecropin B gene
Figure 3.2 shows the process used to synthesize the preprocecropin B gene and 
construct the baculovirus transfer vector pBCE37. Instead of cloning cDNA from 
cecropia moth, the gene was synthesized by fusing the cecropin B preprosequence (CE) 
with the mature peptide-encoding gene in plasmid pLDBI. The use of plasmid pLPV9 
and CE sequence described in chapter 2 made it possible to synthesize the 
preprocecropin B gene having the same gene structure as cecropin B in Hyalophora 
cecropia (van Hofsten et al., 1985). The peptide-encoding gene was digested with 
BglQ. and £coRI in plasmid pLDBl, which created 5'-GATCTATGCCG- at the BglU. 
site with ATG as an initiation codon for the gene. BspMi. digestion in pLP37 produced 
5-CTATGCCG- with 5-CTAT protruding. Subsequently, mung-bean nuclease 
treatment digested the protruding nucleotides (CTAT) while leaving 5-GCCG- blunt- 
ended. This allowed the removal of an ATG codon that is not found in the native 
cecropin B gene. Then, in-frame fusion of the CE sequence to the peptide-encoding 
gene could be done.
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Fig. 3.2. Construction of a recombinant baculovirus transfer vector pBCE37. A gene 
encoding preprocecropin B was synthesized by fusing the peptide-encoding region 
from pLDBl with the preprosequence-encoding oligonucleotides (CE) of cecropin B. 
The gene cut with Xbal and ^ e l  from pCE37 was inserted into the Nhel site of 
pJVNhel to yield pBCE37.




























Xbal - Nhel 
( 204 bp ) pJVNhel
polyhedrin promoter 
preprocecropin B ^ c = P-galactosidase
pB C E 3 7
13.82 Kb
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The preprocecropin B gene was sequenced, and it was confirmed that the gene 
encoded a correct preprocecropin B peptide. Compared to the modified prosequence 
shown in chapter 2, this gene encoded the correct prosequence (-AP-EP-). This was 
possible because the cecropin B peptide-encoding gene in the plasmid pLDBl lacked 
ACC nucleotides before a translation initiation codon (ATG) as a Kozak sequence 
(Kozak et al., 1987). As a result, the digestion with BspMi and mung-bean nuclease 
could change the ATG codon to create the correct prosequence of cecropin B. 
Identification of recombinant virus
Recombinant virus pBCE37 was produced by a homologous recombination 
between transfer vector pBCE37 and AcNPV viral DNA cotransfected into Sf9 cells. 
The transfer vector carries a P-galactosidase gene under the control of the plO 
promoter of Autographa califomica nuclear polyhedrosis virus (Vialard et al., 1990). 
The P-galactosidase gene allowed a recombinant virus to form a blue plaque on an agar 
plate containing the chromogenic substrate X-gal. By this visual counting, the 
transformation eflSciency was estimated less than 1%. The purified recombinant virus 
was reinfected in Sf9 cells and further identified by a light microscopy for the absence 
of occlusion bodies. The inserted preprocecropin B in the recombinant virus pBCE37 
was identified by PCR using the same two primers described in chapter 2. The two 
primers made 914 bps PCR products for the recombinant virus pBCE37, and 838 bps 
for the wild-type virus (Fig. 3.3).





Fig. 3.3. Agarose gel analysis of PCR products obtained from wild-type or pBCE37 
recombinant virus-infected Sf9 ceils. The amplified DNA fragments were separated by 
1% agarose gel electrophoresis and run at 100 volts. Lane 1, 1 Kb DNA ladder, lane 2, 
PCR products from wild-type virus; lane 3, PCR products from recombinant virus 
pBCE37.
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Identification of cecropin B expression
The SG cells, infected with an MOI of 50 of the pBCE37 recombinant virus, 
were harvested at 72 hrs postinfection. Cell lysates and culture medium were run on a 
20% SDS-polyacrylamide gel electrophoresis. Cecropin B expression could not be 
differentiated from wild-type virus in the Coomassie blue-stained gel (Fig. 3.4). The 
gel was transferred onto a nitrocellulose membrane and the membrane was 
immunostained with rabbit anti-cecropin B antiserum. While the antiserum showed 
cross-reaction with virus-infected cell lysates in immunoblots, a band unique to the 
recombinant virus was seen both on cell lysates and culture medium (Fig. 3.5). The 
expression was further examined by staining the virus-infected Sf9 cells with FITC- 
labeled anti-cecropin B antibodies. Despite some cross-reaction of antiserum in the 
immunoblot, fluorescence appeared only in the recombinant virus-infected S@ cells, but 
not in the wild-type virus-infected cells.
The molecular weight of expressed peptide in the gel was higher than that of 
mature cecropin B, but lower than 5.5 kd. Since the expression was observed both in 
cell lysates and the culture medium, a signal peptidase was believed to cleave the signal 
peptide (presequence) of cecropin B. However, the resulting procecropin B was not 
further processed to be mature cecropin B in Sf9 cells. In the cecropia moth, 
procecropin B has been known to be processed by an enzyme called a dipeptidyl 
aminopeptidase that cleaved the prosequence (-AP-EP-) (Boman et al., 1989a). This 
result indicates that Sf9 cells do not possess the enzyme to process the prosequence.









Fig. 3.4. Polyacrylamide gel electrophoretic analysis of Sf9 cells infected with 
recombinant virus pBCE37. Sf9 cells and culture medium were separated on 20% 
SDS-PAGE and stained with Coomassie blue. Lane 1, prestained molecular weight 
markers; lane 2, synthetic cecropin B (2 pg); lane 3 & 5, wild-type virus-infected Sf9 
cells and culture medium; lane 4 & 6, pBCE37 recombinant virus-infected Sf9 cells and 
culture medium.
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Fig. 3.5. Immunoblot analysis of peptides expressed in Sf9 cells infected with 
recombinant virus pBCE37. After electrophoresis, the proteins were transferred onto 
nitrocellulose membranes and immunostained with anti-cecropin B antiserum. Lane I, 
prestained molecular weight markers; lane 2, synthetic cecropin B (0.2 ng); lane 3 & 6, 
wild-type virus-infected S£9 cells and culture medium; lane 4 & 6, pBCE37 
recombinant virus-infected SG cells and culture medium.
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Time course expression of cecropin B
Figure 3.6 shows the time course of procecropin B expression in pBCE37 
recombinant virus-infected S 0  cells. The peptide was first detected at 24 hrs 
postinfection in cell lysates and the expression was consistent after 24 hrs. In culture 
medium, the expression band first appeared at 48 hrs postinfection.
Stability of cecropin B peptide in Sf9 cell lysates, FBS and tobacco leaf extracts 
To determine the stability of cecropin B in various biological samples, 
chemically synthesized cecropin B was incubated with Sf9 cell lysates, fetal bovine 
serum, and tobacco leaf extracts, respectively. The stability was evaluated in 
immunoblots. Final concentration of cecropin B peptides was 10 pg/ml. The peptide 
degraded in 1 hr in Sf9 cell lysates (Fig. 3.7). Although the immunoblot in this assay 
was not sensitive enough to see the kinetics of degradation, this result indicates that 
cecropin B may not be stable in the cytoplasm. This observation was supported by the 
previous work in chapter 2, where no cecropin analog SI peptide was detected in the 
construct designed for expression as cytoplasmic peptides. The stability o f cecropin B 
peptide was further investigated in the presence of 10% fetal bovine serum in which Sf9 
cells were cultured. No peptide degradation was observed in the serum for 20 hrs. 
When tobacco leaf extracts were incubated with the peptide, degradation was observed 
to have occurred more quickly than in the Sf9 cell lysates (Fig. 3.7).
Effects of FBS and cecropia hemolymph on antibacterial activity of cecropin B
Antibacterial activity of cecropin B was investigated in the presence of fetal 
bovine serum and cecropia hemolymph, respectively (Fig. 3.8). The peptide killed 10®
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Fig. 3.6. Time course of expression in pBCE37 recombinant virus-infected S© cells. 
The ceils infected with the virus at an MOI of 50 were harvested at different time 
intervals. The expressed peptides were detected in immunoblots. Lane 2-6 were 
loaded with 17 |il of each cell lysate harvested at 24 hrs, 48 hrs, 72 hrs, 96 hrs, and 120 
hrs postinfection, respectively. Lane 7-11 were loaded with 17 tU of the corresponding 
culture medium. Lane 1 shows prestained molecular size markers.




Fig. 3.7. Stability o f cecropin B in dififerent biological fluids. The peptide (10 |ig/ml) 
was incubated with Sf9 cell lysate (A), fetal bovine serum (B), and tobacco plant 
extract (C) for 20 hrs. At time intervals (1 hr, 8 hrs, and 20 hrs), the samples were 
collected and run on 20% SDS-PAGE. The stability was determined in immunoblots.








Fig. 3.8. Effect of fetal bovine serum and cecropia hemolymph on cecropin B activity 
against E. coli DH5a. The ceils were incubated with cecropin B (4 pg/ml) and FBS or 
cecropia hemolymph in 10 mM sodium phosphate buffer, pH 7.4 for 60 min at 3T’C.
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E. coli cells when it was used at 4 ^g/ml. In the presence of 10% FBS the killing was 
not altered. The activity of the peptide was slightly inhibited by 10% cecropia 
hemolymph but all cells were eventually killed in 60 min.
Discussion
The experiments in this chapter describe the expression of cecropin B using a 
recombinant baculovirus and test the stability of the peptide in different bioloÿcal 
samples. Although the genomic DNA sequence and the cDNA sequence for cecropia 
cecropin B were reported several years ago (van Hofsten et al., 1985; Gudmundsson et 
al., 1991), peptide-level expression has not been clearly defined. This is in part due to 
the relative difGculty in making antiserum against antimicrobial peptides including 
cecropin B. As a result, detection of expression might be impossible without a high 
level o f expression. In chapter 2, the expression of cecropin analog SI could be 
detected in S 0  cells infected with recombinant baculoviruses in immunoblots. Thus, it 
would be necessary to investigate the expression of cecropin B in the same expression 
system.
A gene encoding preprocecropin B was used in this experiment by fusing the 
cecropin B preprosequence-encoding region in fi’ame with the mature peptide-encoding 
gene. Cecropin B preprosequence was added because peptide expression might not be 
stable in the cytoplasm as seen in the expression of cecropin analog SI in chapter 2. 
From immunoblots and immunofluorescence staining, cecropin B was expressed both in 
Sf9 cells and in the culture medium. While the expression was low, there was a stable 
expression for cecropin B in Sf9 cells. For unknown reasons, secretory proteins have
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not been as well expressed as cytoplasmic or nuclear proteins in the baculovirus system 
(Jarvis et al., 1993). Although S 0  cells are known to provide most protein processing 
pathways found in higher eukaroytes, it is unlikely that the cells possess an enqmie to 
process preprocecropin into mature cecropin. In Sf9 cells, translated preproceceropin 
B was observed to be processed only at the signal peptide by a signal peptidase. The 
resulting procecropin B was secreted in the culture medium without being further 
processed. In the cecropia moth, the next step was to cleave the prosequence by a 
dipeptityl aminopeptidase that was purified fiom the hemolymph of cecropia pupae 
(Boman et al., 1989a). Sf9 cells or fetal bovine serum are not likely to possess this 
enzyme or other dipeptidyl peptidases which have been described in many different 
sources (Yaron and Naider, 1993).
Cecropin B peptides were not stably maintained in the presence of Sf9 cell 
lysates, indicating that the peptides may not be stable in the cytoplasm. Although Sf9 
cells were lysed by viral infection and cytoplasmic contents released, expressed 
procecropin B was stable in the culture medium. In chapter 2, the stable expression of 
cecropin analog SI was explained by possibly forming aggregates between the 
expressed analog peptides and fetal bovine serum. This was indirectly shown by 
inhibition of antibacterial activity of cecropin analog SI peptides by the serum (Fig. 
2.10). However, cecropin B is not likely to bind to fetal bovine serum. Cecropin B 
killed E. coli cells efBciently both in the absence and in the presence of 10% FBS, 
which means that cecropin B remains as fi-ee peptides in the serum. Although 
procecropin B is thought to be biophysically different fi'om cecropin B, it is not clear
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how the expressed procecropin B remains stable in the cytoplasmic contents released 
from Sf9 cells after viral infection.
As shown in Fig. 3.8, antibacterial activity of cecropin B was not strongly 
inhibited by 10% cecropia hemolymph. This explains how effectively cecropins kill 
bacteria in insect hemolymph. Insect-derived antimicrobial peptides are released into 
insect hemolymph and effectively kill pathogens in the presence of hemolymph. In 
contrast, mammalian-derived defensins are known to be inhibited strongly by blood or 
plasma. Their antimicrobial action usually occurs in phagocytic cells, where granules 
fuse with a pathogen-ingested vacuole to form a phagolysosome. In addition to 
phagocytic cells, the defensins are found on mucosal surfaces of trachea, intestine, and 
tongue (Diamond et al., 1991; Jones and Bevins, 1992; Schonwetter et al., 1995) 
where the peptides make no contact with blood, indicating that mammalian blood 
and/or antimicrobial peptides are well developed to avoid cytotoxic effect of the 
peptides on host cells. At this point, it is not known how cecropins kill pathogens in 
mammalian in vivo systems. Although Fig. 3.8 shows that antibacterial activity of 
cecropin B is not inhibited by 10% fetal bovine serum, more in vivo experiments are 
needed to determine the effectiveness of insect-derived cecropins in mammalian 
systems.
Cecropin B was observed to be degraded in tobacco leaf extracts, showing that 
the peptide may not be stably expressed in that plant. Recent works revealed that no 
bacterial resistance was found in cecropin B-encoding transgenic plants. While the 
gene was transcribed under the control of a double cauliflower mosaic virus 35S
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promoter, no expression was detected at the peptide-level (Florack et al., 1995; AUefs 
et al., 1995). Insect-derived cecropin genes may not be good candidates for making 
transgenic plants that provide them against pathogens. The gene products are believed 
to be susceptible to proteolytic enzymes. Additionally, it is unlikely that promoters for 
plant transgenic systems are strong enough to produce a high level of the peptide.
In conclusion, cecropin B was stably expressed in Sf9 cells using a baculovirus 
vector although no stable expression of cecropins had been detected previously 
(Yamada et al., 1990; Hellers et al., 1991). With the help of anti-cecropin antibodies, 
low levels of expression could be detected in Sf9 cells. This result indicates that insect- 
derived cecropins could be produced by expression of their genes in cultured Sf9 cells. 
However, some aspects should be considered for the future genetic approach. First, 
the prosequence of cecropin B may not be processed, which affects the bioactivity of 
the peptide. Second, there is a need to use a strong promoter to produce enough 
peptides to kill pathogens. Third, the effect of cecropins on host animals needs to be 
evaluated. The native cecropin B, different from mammalian-derived defensins or 
cecropin analog SI, shows little binding to serum. These data indicate that cecropins 
can be used for killing pathogens in blood if their effect on host cells is minimal.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER FOUR 
EXPRESSION OF CECROPIN ANALOG SI AND CECROPIN B USING 
BACTERIAL FUSION PROTEINS
Over the past decade, many antimicrobial peptides have been discovered in 
different biological sources (Boman, 1995; Nicolas and Mor, 1995). These peptides 
are small, ranging between 12 and 50 residues in size, and contain multiple lysine and 
arginine residues. Based on their amino acid compositions, antimicrobial peptides can 
be divided into two classes: linear peptides and cyclic peptides. Peptides such as 
cecropins, magainins, and melittin consist of a linear polypeptide chain and usually form 
a strong a-helical structure in hydrophobic solvents. On the other hand, cysteine- 
containing peptides form an intramolecular loop structure with one or more disulfide 
bridges and have a tendency to form P-sheet structures. Most peptides in this class are 
found in granules o f mammalian phagocytic cells although insect defensins can also be 
grouped in this class. Despite their structural differences, both groups of peptides are 
proposed to form membrane pores and lyse cells by osmotic shock.
Antimicrobial peptides have been isolated and purified fi'om a variety of 
biological samples. Most insect-derived peptides appear to be isolated fi'om insect 
hemolymph following injection of bacteria, while mammalian peptides are likely to be 
contained in phagocytes or secretory cells. In the past, antimicrobial peptides were 
purified from those biological samples, a process that requires large amounts of 
material and yields very small amounts of purified peptides. To produce large amounts 
o f peptides, the solid phase chemical synthesis has proven useful (Merrifield, 1986).
75
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Many different antimicrobial peptides including cecropins (Boman et al., 1989; Fink et 
al., 1989), magainins (Zaslofif et al., 1988), and their analogs (Jaynes et al., 1988; 
Zaslofif et al., 1988; Wade et al., 1990) have been synthesized by this method. One 
class o f peptides, defensin-type peptides, are especially difScult to chemically 
synthesize due to the presence of disulfide bridges. The chemical synthesis method, 
while useful, has some disadvantages. While producing accurate synthesis for smaller 
peptides, the fidelity of synthesis is decreased as the size is increased. In addition, the 
method uses large amounts of activated amino acids for synthesis, making peptides 
very expensive. The scale of production is limited and organic waste products are 
formed. The development of a bacterial expression system would allow for large scale 
production and would be helpful for peptide research and its medical applications.
However, direct expression of antimicrobial peptides in bacteria has not been 
achieved due to their toxicity to bacterial host cells. One way to solve this problem is 
to use fusion protein expression. In this system, carrier proteins can be used for an 
affinity purification of fusion proteins, either with antibodies or with ligands specific for 
the carrier proteins. Peptide parts can be separated from carrier proteins by chemical 
or enzymatic cleavage. Previously, attempts have been made to express and purify 
antimicrobial peptides using bacterial fusion proteins. Cecropin A was fused with part 
of an arabinose enzyme and the resulting fusion protein was observed to accumulate in 
inclusion bodies. Then, the cecropin A was purified after cyanogen bromide cleavage 
of the fusion protein (Callaway et al., 1993). In another study, the bacterial fusion 
system was extensively studied using four different fusion proteins (Piers et al., 1993).
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This chapter aims to determine how cecropin B and cecropin analog SI peptides can be 
expressed in bacterial fusion protein systems. They were fused either with C-terminal 
truncated protein A or with maltose-binding protein (MBP).
Materials and methods 
Bacteria strains and culture media
Staphylococcus aureus RN4220 kindly provided by Novick (Kreiswirth et al., 
1983) and Escherichia coli DH5a were used in this experiment. E. coli srains were 
propagated in Luria broth (Sambrook et al., 1989) at 37®C and S. aureus strains were 
grown in Tryptic Soy Brotli (Difco) at 37®C.
Plasmids
Plasmid pRIT5 (Nilsson et al., 1985) containing a truncated protein A gene was 
purchased from Pharmacia. Plasmid pMAL-c2 (Maina et al., 1988) was used for the 
construction of maltose binding fusion proteins. The plasmid pRITS expresses 
ampicillin resistance in E. coli and chloramphenicol resistance in S. aureus. The 
plasmid pMAL-c2 expresses ampicillin resistance in E. coli.
Vector constructions
DNA manipulations were essentially performed as described (Sambrook et al., 
1989). For protein A fusion protein gene constructs, plasmid pLPSl (chapter 2) 
containing the cecropin analog 81 peptide-encoding gene was digested with HindUL, 
and filled-in by Klenow fragment of DNA polymerase I which made the enzyme site 
blunt-ended. The resulting plasmid was digested with BaniHL. Gel-purified DNA 
fragments were ligated into the pRITS plasmid digested with HincU and BamlS.. The
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final construct was named pPASl. The cecropin B-encoding gene was derived firom 
plasmid pLP37 (chapter 3). The gene was inserted into the plasmid pRITS using the 
same enzyme sites as in the construction of pPASl. The final construct was named 
pPA37. For maltose binding fusion protein gene constructs, the cecropin B gene or the 
cecropin analog SI gene was cut out of the plasmids pLPB37 or pLPSl with Xbal and 
Nhel enzymes. Each gel-purified DNA fi’agment was inserted into the Xbal site of 
plasmid pMAL-c2. Restriction analysis was done to determine the correct orientation 
of inserted genes. The final constructs were named pMAL-c2-37 and pMAL-c2-Sl, 
respectively.
DNA transformations
Transformation of E. coli DH5a was done as described previously (Sambrook 
et a/., 1989). Transformants were selected on Luria Broth (LB) plates containing 
ampicillin (SO pg/ml). Electroporation was carried out for transformation of S. aureus 
RN4220 strains according to Novick (1991). The strains were cultured overnight in 
Trytic Soy Broth (TSB). One milliliter of the overnight culture was inoculated into 99 
ml of fi'esh TSB medium. The culture was grown at 37®C with gentle shaking to obtain 
an ODeoo of 0.2-0.25. The bacteria were washed 4 times with 0.5 M sucrose by 
centrifuging 20 min at 5,000 rpm at 4°C. After each step, the washing volume was 
reduced firom 100 ml to 25 ml to 10 ml to 5 ml to 1 ml. For electroporation, 160 pi of 
the cell preparation was mixed with 0.5 pg of DNA in a 0.2-cm BioRad Gene Puiser 
cuvette and incubated on ice for 20 min. The cuvette was placed in the sample 
chamber and electroporated by a single pulse with the apparatus (BioRad Gene Puiser
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and Pulse Controller) set at 25 ^F, 2.5 KV, and 200 O. These conditions gave 
electropulse times in the 3.4 msec range. After electroporation, 1.0 ml o f SMMP 
medium (Novick, 1991) was added to the cuvette. The suspension was transferred to a 
sterile tube and put in cold water for 15 min. The tube was then incubated for more 
than 1 hr at 32“C with gentle shaking. The cells were plated on Tryptic Soy Agar 
containing chloramphenicol (10 pg/ml).
SDS-PAGE and Immunoblots
Samples were separated on SDS-polyaciylamide gels by the method of Laemmli 
(1970) in both 12% and 16% separating gels. The gels were stained with Coomassie 
brilliant blue and destained. For immunoblots, separated proteins were 
electrophoretically transferred onto nitrocellulose membranes and immunostained as 
described in chapter 2.
Preparation of E. coli periplasmic proteins
E. coli cells, transformed with pRIT5-derived plasmids, were grown to an 
ODgoo of 1.0. The cell pellet was harvested by centrifugation and resuspended in 1/4 
volume of original culture with a sucrose solution; 2% sucrose, 0.3 M Tris, pH 8.0, 1 
mM EDTA, 0.5 mM MgCb. The resuspended cells were incubated 10 min at room 
temperature, and centrifuged again. The resulting pellet was resuspended in 1/4 the 
volume of the original culture with ice-cold 0.5 mM MgCk, and incubated at 0“C for 
10 min. The suspension was centrifuged and the resulting supernatant was collected.
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IgG-Sepharose affinity column chromatography
Culture supernatants from recombinant S. aureus strains were clarified by 
centrifiiging 20 min at 10,000 rpm, then the pH was adjusted to 7.6 with NaOR The 
supemants were passed over an IgG Sepharose column (Pharmacia) previously 
equilibrated with Tris-saline Tween 20 (TST): 50 mM Tris buffer, pH 7.6, 150 mM 
NaCl and 0.05% Tween 20. The column was washed with 10 bed volumes of TST 
buffer and 2 volumes of 5 mM ammonium acetate buffer, pH 5.0. Fusion proteins were 
eluted with 0.5 M acetic acid, pH 3.4, and lyophilized. Total protein concentrations 
were determined by the method of Bradford (1976) using the Bio-Rad protein assay 
kit.
Cleavage with CNBr
Purified protein A fusion proteins were freeze-dried, dissolved in 70% (v/v) 
formic acid, and cleaved with a 50 times molar excess of CNBr (Sigma) for 24 hrs at 
room temperature. The reaction was stopped by 20-fold dilution with water and 
freeze-drying.
Expression of maltose-binding protein (MBP) fusion proteins in K coli
The E. coli cells transformed with MBP fusion gene constructs were cultured 
overnight in LB medium containing 0.2% glucose and 50 pg/ml ampicillin. The 
overnight culture was inoculated into 100 times volume of fresh medium and was 
grown at 37"C with shaking to an ODaoo of 0.6. Isopropyl-l-thio-P-o- 
galactopyranoside (IPTG) was added to the culture for its final concentration to 0.3 
mM. The culture was incubated 2 hrs and cells were harvested by centrifugation.
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Amylose resin aflinity column chromatography
The E. coli cells were resuspended in 1/20 volume of original culture with 
column buffer: 20 mM Tris, pH 7.4, 0.2 M NaCl, 1 mM EDTA, 10 mM 
mercaptoethanol, 100 pg/ml phenylmethylsulfonyl fluoride (PMSF). The cell 
suspension was sonicated for 5 min using short bursts to break open the cells. The 
sonicated cells were centrifuged 20 min at 12,000 rpm. The resulting supernatant was 
diluted with 5 times the column buffer and loaded on an amylose resin column (New 
England Biolabs). The column was washed with 10 volumes of the column buffer and 
fusion proteins was eluted with the column buffer containing 10 mM maltose (Sigma). 
Cleavage with factor Xa
Purified MBP fusion proteins were dialyzed against distilled water at 4°C and 
lyophilized. The lyophilized fusion protein was resuspended in 20 mM Tris, pH 8.0, 
100 mM NaCl, 2 mM CaClz. Factor Xa (New England Biolabs) was added 1:50 (w/w) 
to MPB fusion proteins. The mixture was incubated at room temperature overnight.
Results
Expression systems for cecropin analog SI and cecropin B peptides
Plasmid pPASl was made by inserting the cecropin analog SI peptide-encoding 
gene into the 3' end of a truncated protein A gene in plasmid pRITS (Fig. 4.1). The 
peptide gene derived fi'om plasmid pLPSl (see chapter 2) was designed to encode only 
the mature peptide part without any leader sequences. Accordingly, a translational 
initiation codon (ATG) followed by a proline codon was located at the 5' end of the 
peptide-encoding region for direct expression. However, this construct did not result
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Fig. 4.1. Construction of the protein A fusion vectors pPASl and pPA37. The vector 
pPASl has a fusion gene coding for protein A and cecropin analog SI. The vector 
pPA37 consists of a fusion gene between protein A and cecropin B.
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in the detectable expression of peptide in bacteria. In the pPASl, the ATG codon for a 
methionine residue provided a chemical cleavage site for separating the cecropin analog 
SI from carrier proteins. Plasmid pPA37 was constructed by fusing the cecropin B 
peptide-encoding gene with the truncated protein A gene in the pRIT5 (Fig. 4.1). The 
design of cecropin B gene was essentially the same as that of cecropin analog SI gene. 
A translational initiation codon and a proline codon were followed by the mature 
peptide-encoding region. For CNBr cleavage, the 11th methionine residue in native 
cecropin B was replaced by a valine residue in the original gene synthesis.
The pRITS-derived plasmids, pPASl and pPA37, are shuttle vectors with two 
replication origins. One is derived from plasmid pBR322 (Bolivar et al, 1978), so it 
allows the pRITS-derived plasmids to replicate in E. coli. The other replication origin 
derived from plasmid pC194 (lordanescu, 1975) allows for replicating in Gram-positive 
hosts such as Staphylococcus aureus. The truncated protein A in pRITS-derived 
plasmids has the IgG-binding region but lacks the region X, which anchors the protein 
to the peptidoglycan of cell wall. As a result, the protein A or its fusion gene products 
are secreted in Staphylococcus aureus RN4220, and in E. coli are transported to the 
periplasmic region.
Plasmid pMAL-c2-Sl and plasmid pMAL-c2-37 (Fig. 4.2) contained the same 
cecropin analog SI and cecropin B genes used for constructing pPASl and pPA37, 
whose genes were fused into the 3' end of a maltose-binding protein (MBP) gene. 
Expression of these fusion genes requires an inducer since the genes are directed under 
the control of the inducible Ptac promoter. The pMAL-c2-derived plasmids, pMAL-
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Fig. 4.2. Construction of the MBP fusion vectors pMAL-c2-37 and pMAL-c2-S 1. The 
cecropin B- or cecropin analog S 1-encoding gene was inserted into pMAL-c2 to 
produce the fusion vectors.
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c2-Sl and pMAL-c2-37, had a deletion of the MBP signal sequence, which allowed 
fusion proteins to be produced in the cytoplasm.
Expression and purification of protein A fusion proteins
Escherichia coli DHSa transformed with either pRITS, pPA37, or pPASl 
vectors were grown to an OD of 1.0 at 600 nm and the periplasmic proteins were 
isolated. The fusion proteins were analyzed by immunoblots using normal rabbit serum 
(Fig. 4.3). The E. coli cells carrying plasmid pRTTS produced truncated protein A 
molecules with degradation products. The degradation originated from the pRITS- 
derived protein A since the serum did not cross-react with the periplasmic proteins of 
E. coli cells shown in lane 1 of Fig. 4.3. The fusion gene constructs, pPASl and 
pPA37, were transformed, and expressed in the periplasmic region of E. coli. No 
fusion proteins were observed in K coli cells transformed with either pPASl or pPA37 
as shown in lane 3 and 4 of Fig. 4.3. The cecropin peptide parts were not detected 
while the protein A part was degraded. This result indicates that cecropin-derived 
peptides are highly unstable and degraded by proteolytic enzymes in the periplasmic 
region of E. coli. This was confirmed in the expression of CEME peptides in E  coli 
using the protein A fusion protein expression vector (Piers et a i, 1993).
Plasmid pRlTS has the protein A signal sequence which allows C-terminal 
truncated protein A and its fusion proteins to be secreted into the culture medium of S. 
aureus. The extracelluar location o f the gene product would help prevent the 
degradation of fusion proteins by proteolytic enzymes. Plasmids pRTTS, pPA37, and 
pPASl were introduced into S. aureus RN4220 by electroporation. Protein A in
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Fig. 4.3. Immunoblot analysis o f protein A fusion proteins with cecropin B or cecropin 
analog SI. Lane 1, periplasmic proteins of E. coli\ lane 2, periplasmic proteins of 
pRITS-transformed E. coli\ lane 3, periplasmic proteins of pPA3 7-transfbrmed E. coir, 
lane 4, periplasmic proteins of pPASl-tranformed E. coli', lane 5, culture medium of 
pRITS-transformed S. aureus', lane 6, culture medium of pPA37-transformed S. aureus, 
lane 7, culture medium of pPAS 1 -transformed S. aureus.
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pRITS-transformed S. aureus was expressed stably with little degradation of the 
protein as shown in lane S of Fig. 4.3. In the fusion gene constructs. Fig. 4.3 showed 
the size increase of protein A molecules caused by the expression of heterogeneous 
fusion proteins with cecropin analog SI or cecropin B peptides (lane 6 and lane 7). 
However, the cells were observed to produce degradative products as shown in the 
immunoblot.
Culture supernatants containing protein A or fusion proteins were passed over 
an IgG-Sepharose column. While the column was thoroughly washed to remove 
loosely bound fusion proteins, purified fusion proteins demonstrated almost as the same 
protein band patterns as in the immunoblot (Fig. 4.4). This indicates that most of the 
degradation occurred at the C-terminal peptide parts, but not at the IgG binding region 
of protein A. The purified fusion proteins were cleaved by CNBr but cloudy 
precipitates were formed. This precipitation was thought to be stimulated as a result of 
producing the degradative products of fusion proteins.
Expression and purification of MBP fusion proteins
Plasmids, pMAL-c2, pMAL-c2-Sl and pMAL-c2-37, were transformed into E. 
coli DH5a. The cells were grown to an OD of 0.6 at 600 nm and induced with IPTG. 
The cells were harvested and sonicated in colunm buffer. The expression of fusion 
protein with cecropin B was identified by SDS-PAGE (Fig. 4.5). In Coomassie-stained 
gel, the expression of this fusion protein was not highly expressed as compared to the 
high expression of control vector pMAL-c2 where MBP was fused with P- 
galactosidase. When whole cells after IPTG induction were run on the gel, the









Fig. 4.4. SDS-poIyacryiamide gel eletrophoretic analysis of purified protein A fusion 
proteins fi'om transformed S. aureus cells. Lane 1, molecular weight markers; lane 2, 
purified protein A fi'om pRIT5-transformed cells; lane 3, purified protein A-cecropin B 
fusion protein fi'om pPAST-transformed cells; lane 4, purified protein A-cecropin 
analog SI fi'om pPAS 1 -transformed cells.
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Fig. 4.5. SDS-poIyacryiamide gel electrophoretic analysis of MBP-cecropin B fusion 
proteins from transformed & coli cells. Lane 1, molecular weight markers; lane 2, 
pMAL-c2-transformed cells induced by IPTG; lane 3, uninduced pMAL-c2-37- 
transformed cells; lane 4, induced pMAL-c2-3 7-transfbrmed cells; lane 5, purified 
fusion proteins eluted from an amylose column; lane 6, purified fusion protein after 
factor Xa cleavage.
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expression level appeared slightly higher (data not shown), indicating that the fusion 
protein is vulnerable to proteolytic degradation during cell lysis. The addition of 
protease inhibitor, PMSF, in the column buffer helped slightly to reduce the proteolytic 
degradation following the sonication process.
The cytoplasmic extracts from K  coli transformed with the plasmid pMAL-c2- 
37 were purified on an amylose afGnity column. Two major protein bands appeared 
around M.W. 40-45 kd as shown in Fig. 4.5. The upper band was intact fusion 
proteins based on the immunoblot. The lower band appeared to be MBP proteins. 
Besides these two bands, some minor bands appeared on the gel. The results indicate 
that the peptide fused with MBP is not stable and undergoes degradation. In the case 
of pMAL-c2-Sl, where the cecropin analog SI gene was fused to the MBP gene, the 
peptide appeared to be more sensitive to proteolytic degradation.
Factor Xa cleavage of the fusion protein, MBP-cecropin B, produced ceropin 
B-like peptide along with MBP. However, the solution after the enzyme digestion 
appeared cloudy with precipitate. Even in the presence of 10% acetic acid, the 
precipitate was not dissolved. It is not clear whether the cleaved peptide bound to 
MBP. It appeared that degradative products on the purification step or after the factor 
Xa digestion contributed to the precipitation.
Discussion
This chapter describes the expression of two antimicrobial peptides, cecropin B 
and cecropin analog SI, using different bacterial fusion proteins. Since bacteria are 
highly sensitive to cecropins, this could be accomplished by forming fusion proteins
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with protein A or MBP proteins. These carrier proteins also allowed separation of 
fusion proteins from crude samples in a single step by affinity columns. Peptides could 
be released from the carrier proteins by an emymatic or chemical cleavage. It is 
important to make the correct size of antimicrobial peptides for keeping their biological 
activity. Extra amino acids at the N-terminal cecropin sequence led to reduced 
biological activity as shown in procecropins or preprocecropins (Boman et al., 1989a). 
In addition, shortening of the chain length in the N-terminal region also was observed 
to decrease in biological activity (Andreu et al., 1985). Accordingly, a methionine 
codon was engineered to the peptide-encoding genes, and used for providing a specific 
cleavage site for CNBr.
The synthesis o f fusion proteins was directed by using pRITS-derived plasmids 
into the periplasmic space of E. coli and into the culture medium of S. aureus. Proteins 
synthesized by E. coli were collected by osmotic shock while proteins synthesized by S. 
aureus were collected from the culture medium of S. aureus. However, cecropin genes 
fused with truncated protein A resulted in a complete loss of cecropin peptide parts in 
the periplasmic region of £1 coli. Protein A was also degraded heavily by proteolytic 
enzymes in the periplasm of£. coli. In S. aureus, high protection and little degradation 
was observed in truncated protein A molecules secreted into the culture medium. 
Fusion gene constructs were observed to produce fusion proteins in the culture medium 
of S. aureus. This indicates that S. aureus is a better host for these peptides. This was 
confirmed in the expression of other antimicrobial peptide, CEME, where no peptide 
firagment was expressed in E. coli, but a whole fusion protein was produced in S.
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cmreus (Piers et al., 1993). In contrast, alkaline phosphatase in this fusion system was 
expressed more stably in K  coli than in S. cmreus (Nilsson et al, 1985). Probably, S. 
cmreus provides a better expression for truncated protein A molecules or hision 
proteins consisting of low molecular weight peptides.
Production of protein A fusion proteins was high in S. cmreus, and more than 5 
mg of purified fusion proteins could be obtained fi'om 100 ml of culture. However, 
many degradation products were also produced with the fusion proteins. The protein 
containing cecropin peptides precipitated after CNBr cleavage. This may be caused by 
hydrophobic interaction between hydrophobic surface of protein exposed after CNBr 
cleavage and amphipathic cecropin peptides. Thus, it is important to produce fusion 
proteins without degradation in order to release and purify peptides after CNBr 
cleavage. The degradation of fusion protein may be prevented by different approaches. 
First, a synthetic sequence encoding negatively-charged peptides can be inserted 
between carrier proteins and cationic peptides. This design allows the formation of 
secondary structure between the inserted anionic linkers and cationic peptides by 
electrostatic interactions. Insertion of a synthetic preprosquence of defensin was 
reported to protect the fusion protein of glutathione S-transferase (GST) and defensin 
fi'om proteolytic degradation, although the peptide could not be purified due to the 
presence of 12 methionine residues in GST (Piers et al., 1993). Second, the stable 
expression of fusion proteins can be improved using different host cells. The 
expression of protein A fusion proteins with cecropin A was reported in a baculovirus 
expression system, where more stable protein A fusion proteins were produced
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(Andersons et al., 1991). This indicates that protein A fusion proteins can be produced 
stably by using di£ferent host cells. Although recombinant baculoviruses showed the 
stable expression of protein A fusion proteins for cecropins, the development of 
bacterial expression system will be necessary to produce the peptides on a large scale. 
The pRITS-derived plasmids can be replicated in many Staphylococcus species. S. 
aureus strains used in this experiment are known to produce many exoenzymes that 
make them pathogenic. It is not clear that these enzymes degrade the fusion proteins in 
S. aureus. However, nonpathogenic Staphylococcus species like S. epidermidis, S. 
xylosus, etc. could be better organisms for the stable expression of fusion proteins if 
transformation can be done easily in these strains.
The MBP fusion protein system was chosen for several reasons. First, the MBP 
protein consists of 370 amino acid residues, which is larger in size than truncated 
protein A. This protein would be better for forming a compact structure with cecropin- 
type peptides. Second, the MBP vector is provided with a factor Xa cleavage site at 
the C-terminal end of MBP. The enzyme cleavage allows for releasing peptides from 
the MBP fusion protein. Also, it is easier to immunologically study the MBP products 
than protein A products wherein protein A interferes with immunoassays.
The MBP fusion vectors, pMAL-c2-Sl and pMAL-c2-37, resulted in the 
expression of fusion proteins with little degradation. Although the fusion protein 
expressed from pMAL-c2 was reported to constitute up to 20% to 40% of the total 
cellular proteins, the fusion proteins obtained from each construct herein was low. 
Cecropin B-fused MBP proteins were more stably expressed than cecropin analog Si-
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fused proteins. Perhaps the latter hision protein is not stable in the cytoplasm. In 
addition, both fusion proteins were observed to be degraded upon cell lysis. This 
degradation might be attributed to the exposure o f fusion proteins to periplasmic 
proteases or outer membrane proteases during cell lysis. The addition of PMSF and 
EDTA inhibited slightly the activity of proteases, but that did not result in high yield.
In conclusion, cecropin-type peptides could be expressed in bacterial expression 
systems. Although bacteria are sensitive to the peptides, expression was accomplished 
through the formation of fusion proteins with protein A or MBP proteins. Extracellular 
secretion of fusion proteins was shown to be more effective for the production of 
peptides as in the production of protein A fusion proteins in S. aureus. However, in 
order to allow for purifying the peptides, fusion proteins should be expressed more 
stably. In the case of protein A fusion proteins, the stable expression of fusion proteins 
may be improved by using nonpathogenic Staphylococcus strains that are known to 
produce less exoenzymes than S. aureus, or by inserting anionic peptide-encoding 
oligonucleotide linkers between carrier proteins and cecropin peptides.
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CHAPTER FIVE 
CONCLUSION
The overall goals of this research were focused on how a designed antimicrobial 
peptide could be expressed in a gene expression system. Although many peptides have 
been designed and synthesized in the past, cecropin analog SI was chosen for several 
reasons. First, this peptide, despite 54% amino acid substitution of cecropin B, was 
designed fulfilling the common structural motif in antimicrobial peptides. These data 
show that the bioactivity is directed by the physical structure, not by primary sequence. 
Second, a gene encoding only the mature analog peptide was initially introduced into 
plants, but expression of the peptide was not detected in the plants. This result led to 
questions regarding the best genetic approach for a designed antimicrobial peptide. 
Since gene expression is a complicated process, one suggestion was made to determine 
the usefulness of an artificially designed gene. Instead o f using transgenic systems, the 
use of a well-established expression system was preferred. My results indicated that 
the designed peptide was unstable in the cytoplasm, so the original gene was modified 
to be expressed as a secretory peptide.
The cecropin analog SI gene was modified to code for a peptide by fusing the 
preprosequence-encoding region of cecropin B with the mature analog peptide- 
encoding gene. The resulting gene, preprocecropin analog SI, encodes the signal 
peptide (22 amino acids), a modified prosequence (5 amino acids), and a mature 
peptide (36 amino acids). This gene construct was observed to express the propeptide
95
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in Sf9 cells after the signal peptide was processed. However, the cleavage of the 
prosequence could not be confirmed in S@ cells with this gene construct because the 
prosequence (-AP-DMP-) was modified fi'om that o f cecropin B (-AP-EP-) during 
gene construction.
However, the stable cytoplasmic expression of this peptide may not be feasible. 
No peptide was detected in the original gene construct intended for expression in the 
cytoplasm, indicating that, if expressed, the peptide is highly susceptible to proteolytic 
enzymes in the cytoplasm. Although the baculoviruses lysed the Sf9 cells and liberated 
the cytoplasmic contents into the culture medium, the expressed peptide remained 
stable in the medium. In vitro experiments show that the antibacterial activity of the 
cecropin analog SI peptide was strongly inhibited in the presence of fetal bovine serum. 
The inhibition is believed to be caused by aggregating the peptides with the serum. 
Probably, fetal bovine serum binds to the secreted peptides and helps prevent the 
peptides fi'om proteolytic degradation.
Contrary to the previous observations (Yamada et al., 1990; Hellers et al., 
1991), cecropin B was stably expressed in Sf9 cells. However, the prosequence of 
cecropin B was not cleaved in Sf9 cells, indicating that the cells do not have a 
dipeptidyl aminopeptidase to process the procecropin B. While no degradation of 
expressed procecropin B was observed in the culture medium, cecropin B peptides 
were very unstable in Sf9 cell lysates or tobacco plant extract. Fetal bovine serum may 
not be a factor to protect the stability of procecropin B, unlike the cecropin analog SI. 
Antibacterial activity of cecropin B was not inhibited by 10% fetal bovine serum. This
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result indicates that cecropin analog SI, although designed from an insect-derived 
cecropin B peptide, is biophysically different from that peptide. While most o f the 
insect-derived peptides are known to be active against pathogens in insect hemolymph, 
the bioactivity of cecropin analog SI is inhibited in the presence of serum. On the 
interaction with serum, the cecropin analog SI peptide acts likely a mammalian-derived 
defensin whose activity is known to be inhibited by serum.
To permit expression of cecropin B and cecropin analog SI in bacteria, fusion 
protein systems were used. Fusion proteins overcame the potential ability o f the 
peptides to kill their host cells and allowed for separating them in a single-step 
purification. Peptides fused with protein A were observed to be produced in culture 
medium of S. aureus, but not in E. coli. The fusion proteins were purified on an 
affinity column, but peptides could not be separated from carrier proteins after CNBr 
cleavage. This was in part due to the degradative products of fusion proteins in S. 
aureus, which resulted in protein aggregation after the cleavage. The MBP fusion 
system produced relatively stable fiision proteins for cecropin B, but the expression 
level was not high enough to allow isolation of the peptide. This result shows that 
purification, in addition to stable expression of fusion proteins, is important to obtain 
antimicrobial peptides produced in bacteria.
In conclusion, a designed antimicrobial peptide, cecropin analog SI, could be 
expressed as a secretory peptide in Sf9 cells, although it is still unknown whether all 
designed antimicrobial peptides would be expressed in this gene expression system. 
However, the secreted cecropin analog SI peptide may not be effective in killing
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pathogens in manunalian blood. The analog peptide shows high a£5nity to fetal bovine 
serum, which eventually neutralizes the antimicrobial activity of the peptide as seen in 
mammalian-derived defensins. Thus, the peptide would be designed to be targeted into 
vesicles o f phagocytic cells, which help prevent binding to the serum, and kill 
intracellular pathogens in phagocytic cells. This possibility may be the most effective 
use of designed antimicrobial analogs in mammals.
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